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Abstract 
Genetic perturbations and foreign chemicals can result in a multitude of changes across a wide 
range of biochemical processes in a biological system.  These perturbations may affect the 
metabolome, the small molecule metabolites in an organism.  Recently, liquid-chromatography 
coupled to mass spectrometry (LC-MS) technology has been used to quantify large proportions 
of the metabolome, however standardized protocols are not yet available for use with Drosophila 
melanogaster.  Here, I developed an ion-pairing LC-MS protocol for the metabolomic 
characterization of D. melanogaster and demonstrated its implementation in establishing the 
metabolomic profile of flies under oxidative stress and in the metabolic profiles of four different 
Drosophila species.  I demonstrated that this new method allows for the detection of otherwise 
difficult metabolites and that it is repeatable and sensitive with acceptable levels of ion-
suppression, matrix effects, limits of detection and quantification.  I then used this method to 
determine and quantify the metabolomic fingerprints of loss of Superoxide dismutase activity 
and paraquat-induced stress.  Comparing and contrasting the effects of these two sources of 
oxidative stress, I document both similarities and stressor-specific effects. 
Keywords 
LC-MS, Metabolomics, Drosophila melanogaster, oxidative stress  
 iv 
Co-Authorship Statement 
Chapter 1 of this thesis concentrates on a review of many technological and biological concepts 
important to this project.  I am the sole author of this chapter.  Thomas Merritt contributed 
insight into experimental design and the conception of the projects, along with grammatical and 
structural guidance in all chapters of this thesis.  
Chapter 2 is a restructured document of a published article in the Journal of Chromatography B.  
This article entitled, A novel ion-pairing chromatography LC-MS protocol for the study of 
biologically relevant polar metabolites, is authored by myself (first author), Teresa Z. 
Rzezniczak (TZR), Kevin K. Guo (KKG), Aiko Barsch (AB), and Thomas J. S. Merritt (TJSM).  
TZR contributed technical assistance during method development, validation, and various 
metabolomic analyses.  KKG and AB contributed to the technological and conceptual design of 
the protocol developed in this thesis. 
Chapter 3 is an early manuscript intended for submission into the journal, Free Radical Biology 
and Medicine.  As in Chapter 2, I am the first author with TZR, Tony L. Parkes (TLP), and 
TJSM as authors on the manuscript.  TZR contributed technical assistance for part of the 
metabolomic analysis in this manuscript. TLP has contributed the fly lines and his expertise with 
this particular biological system.  
Chapter 4 is a discussion of aspects covered in this thesis including avenues for future research.  
I am the sole author to this chapter with conceptual, structural, and grammatical guidance from 
TJSM.   
 v 
Acknowledgements 
In the past two and a half years as an M.Sc. student at Laurentian University, I have had the 
pleasure of working with extraordinary people who have made my success possible.  I would 
first like to thank my supervisor Dr. Thomas Merritt, for providing me with the wisdom, tools, 
and opportunities to become more of a well-rounded scientist.  I would also like to thank Dr. 
Merritt for his unwavering support throughout all stages of my masters. 
 Secondly, I would like to thank my committee members Dr. Eric Gauthier, Dr. James 
Watterson, and Dr.Tony Parkes.  My committee members have provided me with support and 
feedback that has positively affected my thesis and prepared me for the challenges I will face in 
the future. 
Lastly, I would like to thank my family and friends who have supported me and made my 
experience throughout these years much more rewarding and enjoyable.  I would like to thank 
my colleagues Teresa Rzezniczak, Ryan Auld and David Bing, without whom I would not have 
been able to complete my thesis, both in a technical sense and in comradery.  
 vi 
Table of Contents 
Abstract .......................................................................................................................................... iii	  
Keywords ....................................................................................................................................... iii	  
Co-Authorship Statement ............................................................................................................... iv	  
Acknowledgements ......................................................................................................................... v	  
Table of Contents ........................................................................................................................... vi	  
List of Tables .................................................................................................................................. x	  
List of Figures ................................................................................................................................ xi	  
List of Appendices ........................................................................................................................ xii	  
List of Abbreviations ................................................................................................................... xiii	  
Chapter 1 ......................................................................................................................................... 1	  
1	   Introduction ................................................................................................................................ 1	  
1.1	   Overview ............................................................................................................................. 1	  
1.1	   Metabolomics ...................................................................................................................... 1	  
1.2	   Metabolite detection methods ............................................................................................. 2	  
1.3	   Mass spectrometry based metabolomics ............................................................................. 3	  
1.3.1	   Electrospray ionization source ................................................................................ 5	  
1.3.2	   Column chemistry and ion pairing chromatography .............................................. 7	  
1.4	   Drosophila melanogaster:  Model for LC-MS analysis ..................................................... 9	  
1.5	   Reactive oxygen species and oxidative stress ................................................................... 10	  
1.6	   Superoxide dismutase ....................................................................................................... 10	  
Chapter 2 ....................................................................................................................................... 12	  
2	   A novel ion-pairing chromatography LC-MS metabolomics protocol for the study of 
biologically relevant polar metabolites .................................................................................... 12	  
2.1	   Introduction ....................................................................................................................... 12	  
 vii 
2.2	   Materials and methods ...................................................................................................... 15	  
2.2.1	   Chemicals and reagents ......................................................................................... 15	  
2.2.2	   Fly stocks .............................................................................................................. 15	  
2.2.3	   Culture conditions ................................................................................................. 16	  
2.2.4	   Chemically induced oxidative stress ..................................................................... 17	  
2.2.5	   Sample preparation ............................................................................................... 17	  
2.2.6	   Instrumentation ..................................................................................................... 18	  
2.2.7	   Data analysis ......................................................................................................... 18	  
2.2.8	   Quantification and Validation procedure .............................................................. 19	  
2.3	   Results and discussion ...................................................................................................... 20	  
2.3.1	   Method development ............................................................................................ 20	  
2.3.2	   Ion suppression/enhancement ............................................................................... 22	  
2.3.3	   Matrix effects ........................................................................................................ 23	  
2.3.4	   Linearity and quantification .................................................................................. 25	  
2.3.5	   Reproducibility ..................................................................................................... 27	  
2.3.6	   Application ............................................................................................................ 30	  
2.3.7	   The effect of loss of cytosolic Superoxide dismutase function ............................ 30	  
2.3.8	   The effect of paraquat induced stress .................................................................... 31	  
2.3.9	   Species specific metabolic signature .................................................................... 34	  
2.3.10	   Conclusion ............................................................................................................ 35	  
Chapter 3 ....................................................................................................................................... 39	  
3	   LC-MS metabolomic analysis of a Sod-null mutant and paraquat induced stress in 
Drosophila melanogaster ......................................................................................................... 39	  
3.1	   Introduction ....................................................................................................................... 39	  
3.2	   Materials and methods ...................................................................................................... 41	  
3.2.1	   Fly stocks and treatment ....................................................................................... 41	  
 viii 
3.2.2	   LC-MS parameters ................................................................................................ 43	  
3.2.3	   Data handling and statistical tests ......................................................................... 44	  
3.3	   Results ............................................................................................................................... 45	  
3.3.1	   Metabolomic analysis of a Sod-null mutation ...................................................... 45	  
3.3.2	   Metabolomic analysis of paraquat-induced stress ................................................ 45	  
3.3.3	   Metabolic comparison between stresses ............................................................... 46	  
3.3.4	   Metabolic pathways affected by a genetic and chemically induced oxidative 
stress  ................................................................................................................ 48	  
3.3.5	   Glutathione metabolism and related pathways ..................................................... 49	  
3.3.6	   Glutamine and purine metabolism ........................................................................ 49	  
3.3.7	   Pantothenate and CoA biosynthesis ...................................................................... 50	  
3.3.8	   Changes to amino acid concentrations .................................................................. 50	  
3.4	   Discussion ......................................................................................................................... 57	  
3.4.1	   Oxidative stress leads to changes in the metabolic profile of Drosophila 
melanogaster .............................................................................................................  57	  
3.4.2	   Glutathione metabolism ........................................................................................ 57	  
3.4.3	   NADPH, the pentose phosphate pathway, and glucose metabolism .................... 58	  
3.4.4	   Oxidative phosphorylation and purine metabolism .............................................. 60	  
3.4.5	   Evidence of OS associated neurodegeneration ..................................................... 61	  
3.4.6	   Amino acid metabolism affected by OS ............................................................... 61	  
3.4.7	   Conclusions and future directions ......................................................................... 62	  
Chapter 4 ....................................................................................................................................... 64	  
4	   General conclusions and future work ....................................................................................... 64	  
4.1	   Expanding metabolite coverage ........................................................................................ 64	  
4.1.1	   Chromatography:  Implications for increased metabolite detection ..................... 64	  
4.1.2	   Sample preparation ............................................................................................... 67	  
 ix 
4.1.3	   Broadening the scope of mass analyzer ................................................................ 69	  
4.2	   Expanding biological significance .................................................................................... 70	  
4.2.1	   Genetic background and oxidative stress .............................................................. 70	  
4.2.2	   Paraquat induced stress and genetic background .................................................. 73	  
4.2.3	   Species-specific metabolic profiles ....................................................................... 74	  
4.3	   LC-MS technology beyond oxidative stress and Drosophila ........................................... 76	  
4.4	   Conclusion ........................................................................................................................ 77	  
References ..................................................................................................................................... 78	  
Appendices .................................................................................................................................... 91	  
 
  
 x 
List of Tables 
Table 1: Liquid chromatography gradient .................................................................................... 21	  
Table 2: Retention times, linearity of calibration, limits of detection and limits of quantification
............................................................................................................................................... 26	  
Table 3: Reproducibility of LC-MS signals .................................................................................. 28	  
Table 4: Summary of metabolomic comparisons ......................................................................... 49	  
Table 5: Pathway analysis of Sod-null genotype .......................................................................... 51	  
Table 6: Pathway analysis of paraquat induced stress. ................................................................. 54	  
  
 xi 
List of Figures 
Figure 1: Combined extracted peak chromatograms of prepared standards in solution using 
solvent A. .............................................................................................................................. 21	  
Figure 2: Ion suppression/enhancement caused by the ion-pairing reagent, DAA. ...................... 24	  
Figure 3: Matrix effects in Drosophila homogenate. .................................................................... 25	  
Figure 4: Heat map of metabolite profiles for the top 30 significantly different metabolites for 
Sod-nulls vs. T5 control lines. ............................................................................................... 32	  
Figure 5: Principal component analysis (PCA) loadings and score plots representing the 
metabolic profiles of the Sod-nulls vs. T5 control lines. ...................................................... 33	  
Figure 6: Heat map of metabolite profiles for the top 30 significantly different metabolites for 
Paraquat treated T5 lines vs. T5 control lines. . .................................................................... 36	  
Figure 7: Heat map of metabolite profiles for the top 30 significantly different metabolites for 
four Drosophila species. ....................................................................................................... 37	  
Figure 8: A comparison of metabolite levels between (A) Sod-nulls vs. T5 controls, (B) Paraquat 
treated T5s vs. control T5s, (C) Four Drosophila species. ................................................... 38	  
Figure 9: PCA scores and loading plots of the metabolic profiles representing A) the Sod-null vs. 
T5 control lines and B) T5 control lines under paraquat stress and control parameters. ...... 47	  
Figure 10: Heat maps of the metabolic profiles, consisting of the top 59 significantly different 
features, of A) Sod-nulls vs. T5 controls and B) PQ treated flies vs. controls. .................... 48	  
Figure 11: Pathway analysis ......................................................................................................... 50	  
Figure 12: Simplified metabolic architecture of Sod-null and paraquat induced stress. .............. 56	  
  
 xii 
List of Appendices 
Appendix A: PCA loadings and score plots representing the metabolic profiles of A) paraquat 
treated T5 lines vs. T5 control lines, and B) four Drosophila species. ................................. 91	  
Appendix B: PCA loadings and score plots representing the metabolic profiles of four 
Drosophila species. ............................................................................................................... 92	  
Appendix C: Comparison of transgenic rescue lines with wild-type lines ................................... 93	  
Appendix D: Relative standard deviations (RSD) of the area under the curve, for five replicates, 
of injections containing 16 compounds that elute near the void volume. ............................. 94	  
Appendix E: Significantly altered metabolites in the Sod-null genotype (post-tandem MS) ....... 95	  
Appendix F: Significantly altered metabolites in paraquat treated flies (post-tandem MS) ......... 97	  
 
  
 xiii 
List of Abbreviations 
 
Abbreviation    Definition 
Å     Angstrom 
ADP     Adenosine 5’-diphosphate 
AMP     Adenosine 5’-monophosphate 
ANOVA    Analysis of variance 
APCI     Atmospheric pressure chemical ionization 
ATP     Adenosine 5’-triphosphate 
AUC     Area under the curve 
oC     Degree Celsius 
C-18     Octadecyl silane 
CDP     Cytodine diphosphate 
CE     Capillary electrophoresis 
CoA     Coenzyme A 
CYA     Cornmeal-yeast-agar 
D     Dimensional 
Da     Dalton 
DAA     Diamyl ammonium 
DC     Direct current 
DNA     Deoxyribonucleic acid 
EC     Electrochemical 
EI     Electron impact 
ESI     Electrospray ionization 
eV     Electron volt 
FAD     Flavin adenine dinucleotide (oxidized) 
FALS     Familial amyotrophic lateral sclerosis 
FDR     False discovery rate 
FMF     Find molecular features 
g      Gravitational constant 
G6PD     Glucose-6-phosphate dehydrogenase 
GC     Gas chromatography 
GLYP     Glycogen phosphorylase 
GPDH     Glycerol 3-phosphate dehydrogenase 
GSH     Glutathione (reduced) 
GSSG     Glutathione (oxidized) 
HEX     Hexokinase 
HFBA     Heptafluorobutyric acid 
HILIC     Hydrophilic interaction chromatography 
I.D.     Internal diameter 
i.e.     id est 
IDH     Isocitrate dehydrogenase 
IMP     Inosine monophosphate 
IP     Ion-pairing 
IPR     Ion-pairing reagent 
KEGG     Kyoto Encyclopedia of Genes and Genomes 
 xiv 
KO     Knock-out 
kV     kilovolt 
L     Liter 
LC     Liquid chromatography 
LOD     Limit of detection 
LOQ     Limit of quantification 
m/z     Mass-to-charge ratio 
ME     Malic enzyme 
mg     milligram 
min     Minute 
mL     milliliter 
mM     millimolar 
mRNA     messenger ribonucleic acid 
MS     Mass spectrometery 
NAA     n-Acetylaspartate 
NAD     Nicotinamide adenine dinucleotide (oxidized) 
NADH     Nicotinamide adenine dinucleotide (reduced) 
NADP     Nicotinamide adenine dinucleotide phosphate (oxidized) 
NADPH    Nicotinamide adenine dinucleotide phosphate (reduced) 
NMR     Nuclear magnetic resonance 
OS     Oxidative stress 
oTOF     Orthogonal time of flight 
PC     Principal component 
PCA     Principal component analysis  
PGI     Phosphoglucose isomerase 
PGM     Phosphoglucomutase 
pKa     Acid dissociation constant 
ppb     Part per billion 
ppm     Part per million 
PQ     Paraquat 
QC     Quality control 
qTOF     Quadrupole time of flight 
RF     Radio frequency 
RNAi     Interfering ribonucleic acid 
ROS     Reactive oxygen species 
RP     Reversed phase 
RSD     Relative standard deviation 
SOD     Superoxide dismutase (protein) 
Sod     Superoxide dismutase (mRNA) 
SPE     Solid phase extraction 
TBA     Tributylammonium 
TCA     Tricarboxylic acid cycle 
TFA     Triflouroacetic acid 
TOF     Time of flight 
UPD     Uridine 5’-diphosphate 
(U)HPLC    (Ultra) high performance liquid chromatography 
 xv 
µL     microliter 
µm     micrometer 
UMP     Uridine monophosphate 
UV     Ultra-violet 
Vis     Visible 
V     Volt 
w/v     weight per volume 
z     Charge (dimensionless)
 1 
Chapter 1 
1 Introduction 
1.1 Overview 
Organisms rely on a multitude of biological processes that function not in isolation, but in an 
intricate ensemble of interactions.  The study of these interactions has classically been limited to 
investigating isolated features, however advancements in network biology, and technological 
capabilities, have recently made insights into complex networks possible.  In the network 
biology paradigm any phenotypic trait is the sum of all the interactions in a system (Barabási and 
Oltvai, 2004).  Understanding the network biology of an organism requires the quantification of 
these interacting traits using large-scale data acquisition associated with functional genomics.  
Once quantified, these traits make up a profile that can be used to describe a complex phenotype, 
rather than a simple phenotype based on a limited amount of traits.  With this large-scale 
paradigm in mind, the concentration and variation of metabolites in a system can be treated as a 
phenotypic trait that can be quantified and used to infer biological meaning (Kamleh et al., 2008; 
Want et al., 2013).  Metabolites do not exist in isolation, but as components of biochemical 
networks that respond to genetic and environmental factors. Quantifying variation in metabolite 
levels can provide insights into underlying genomic functions and highlight networks of interests 
for future research. 
1.1 Metabolomics 
The complete set of small molecule metabolites in a system is known as the metabolome, and the 
aim of metabolomics is to detect and quantify as large a proportion of the metabolome as 
feasible, given technical and financial constraints (Dettmer et al., 2007).  Recent advances in 
analytical technology allow us to analyze a substantial portion of the metabolome (Kamleh et al., 
2008; t’ Kindt et al., 2010).  Wide-arrayed metabolomic methods offer the advantage of being 
able to discern concentration differences in a broad suite of metabolites in biological samples 
without previous genomic or biochemical information.  These types of “untargeted” studies 
allow us to observe important differences in the metabolome, which may have otherwise been 
overlooked (Kamleh et al., 2008; t’ Kindt et al., 2010). 
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From a genomics perspective metabolites are the products of upstream genomic processes: genes 
are transcribed into mRNA, mRNA is translated into protein, and proteins convert one 
metabolite to another.  Metabolite levels then dictate various complex biological phenomena and 
can therefore be considered a link between genotype and phenotype.  The Isocitrate 
dehydrogenase system in human oligodendroglioma cells is an example of such a connection.  A 
mutation in the Isocitrate dehydrogenase (Idh) gene results in downstream alterations in 
metabolome (phenotype: Reitman et al., 2011).  In this example, a genomic alteration resulted in 
an Idh knock-out (KO), manifesting in loss of transcribed Idh mRNA and functional IDH 
protein.  IDH catalyzes the conversion of the metabolite isocitrate into 2-oxoglutarate.  The 
author’s metabolomic analysis revealed that 2-oxoglutarate was decreased in Idh1 and Idh2 
mutants, as expected.  The overall metabolite picture, however, was much more complicated as 
over 140 metabolites were significantly different in the Idh KO subjects than in control samples 
(Reitman et al., 2011).  The breadth of this effect, 140 individual metabolites, highlights the 
usefulness of broad metabolomic analysis in revealing pleotropic effects of a gene alteration, by 
quantifying small molecule metabolites. 
In contrast to transcriptomics, which involves the detection of polymers of four nucleotide bases, 
or proteomics, which involves the detection of polymers of 20 amino acids, metabolomics 
encompasses a much broader and diverse set of chemicals with a larger variety of 
physiochemical properties.  The diverse set of compounds that make up the metabolome include 
amino acids, cofactors, vitamins, organic acids, sugars, drugs and other external chemicals, 
amongst others.  Due to the wide diversity of compounds found in the metabolome, no single 
analytical platform can analyze it in, entirety, though some platforms can analyze a large suite of 
compounds. 
1.2 Metabolite detection methods 
The most common detection methods in metabolomic studies include ultraviolet-visible (UV-
Vis) spectrophotometry, nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry 
(MS), and electrochemical array (EC-array; Fiehn, 2002; Gamache et al., 2004).  Each of these 
techniques has advantages and disadvantages for analysis of small molecule metabolites, and a 
suite of molecules for which they are best suited.  NMR detection has the advantage of 
elucidating structural information that can be used for the identification of unknown compounds, 
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however it has the disadvantage of higher detection limits and it cannot easily differentiate 
between compounds being analyzed simultaneously as a part of a complex mixture (Wishart, 
2008).  UV-Vis detection shares disadvantages with NMR detection, however it offers simpler 
and more affordable systems, as well as established protocols.  EC-array detection is capable of 
detection limits that are orders of magnitudes lower than any other detection method, however it 
is limited to compounds that are capable of oxidation or reduction (Gamache et al., 2004).  Mass 
spectrometry (MS) displays the largest molecular versatility; it is compatible with a wide range 
of solvents and modifiers, it is able to detect a widest variety of chemicals, and it has 
exceptionally low detection limits that are being driven even lower as technology advances 
(Dettmer et al., 2007).  In contrast to other techniques, accurate mass measurements from mass 
spectrometry can also differentiate between compounds introduced simultaneously, although 
with certain limitations that will be discussed in following sections.  Further, many MS platforms 
are capable of tandem mass spectrometry, in which ions of a single mass are isolated and 
fragmented into reproducible patterns of daughter signals, which can aid in the elucidation of 
unknown compounds (Dettmer et al., 2007).  MS platforms do, however, lack the ability to 
reveal the structural information that NMR analysis is capable of delivering.  Alternatively, a 
combination of MS and NMR approaches can be employed to reveal the identification of a 
metabolite that neither approach can identify on their own (Eyres et al., 2008). 
1.3 Mass spectrometry based metabolomics 
Recent advancements in the technology of mass spectrometry based metabolomics, have made 
the technique more sensitive, versatile, and robust (Dettmer et al., 2007).  Mass spectrometry is a 
powerful technique for determining the identity and concentrations of ions.  Mass spectrometers 
determine the mass of an ion by manipulating it through its various components using 
electromagnetic fields.  In order to be manipulated by electromagnetic fields, compounds need to 
be in a charged, gaseous state.  Charge and mass are the largest factors affecting an ion’s 
movement and the reported unit of measurement in MS is therefore, the mass-to-charge ratio 
(m/z).  The components of a mass spectrometer that manipulate charged molecules are called ion 
guides, or mass analyzers, depending on their purpose. 
Different mass spectrometers contain various forms of ion guides and mass analyzers, including 
various numbers of parallel rods (quadrupoles, hexapoles, etc.), stacked circular structures with 
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decreasingly small radii known as funnels, ion traps, and time of flight (TOF) chambers.  All 
guides manipulate ions under high vacuum pressures to effectively guide ions to detectors while 
removing solvent and neutral gases. Movement is regulated axially, along the length of the 
instrument, and radially, perpendicular to axial movement.  Ion guides confine ions within a 
narrow, radial, path, by interaction of the ion within an in-homogenous radio frequency (RF) 
field.  The RF field will generate points of varying electrical potential energy, which act as 
potential barriers to ions moving within an instrument.  Potential barriers reflect ions travelling 
down a path, and by oscillating the RF field and the location of potential barriers an instrument 
can guide ions within a predetermined path.  Axial movement of ions is achieved with the use of 
a direct current (DC) gradient.  For example, ion funnels have two DC voltage plates at each end 
of the funnel that guide ions through the funnel and the consecutively smaller rings have an 
applied RF frequency that concentrate the ions along a smaller path. 
Multipole mass spectrometers are among the most common types of mass spectrometers used in 
metabolomic studies.  Multipoles consist of a number of metal bars arranged circularly and in 
parallel, creating a path for ions to be manipulated within the bars.  Multipoles and ion-traps, 
variations of the multipole, rely on the stability of an ion trajectory directed through the 
instrument with RF and DC voltages (De Hoffmann, 2005).  If RF voltages alone are used across 
the bars, then ions of various masses can travel through the multipole and it acts as a guide.  If 
both RF and DC voltages are applied to the poles then ions of a certain mass will be stable 
through a trajectory, while unstable masses will exit, or discharge on the poles.  Ion traps are 
based on the same type of stable trajectory principle and the poles can be arranged linearly or 
non-linearly.  The linear ion-trap variation is essentially a quadrupole with two reflecting 
potentials at each end of the quadrupole that trap an ion, while the non-linear variation is 
essentially a quadrupole bent into a ring structure (De Hoffmann, 2005). 
Time-of flight (TOF) mass spectrometers have been used extensively for broad based 
metabolomic studies and rely on the separation of ions down a flight tube (De Hoffmann, 2005; 
Verhoeven et al., 2006).  The time-of-flight (TOF) mass analyzer requires a voltage to accelerate 
ions into a field free drift stage before the ion reaches a detector (De Hoffmann, 2005).  In TOF 
mass spectrometry the time it takes the ion to travel from the accelerated region to the detector is 
inversely proportional to the mass to charge ratio (m/z).  Depending on the ionization source, or 
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components preceding a TOF chamber, ions entering the TOF component are often travelling 
perpendicularly to the path of flight, necessitating an orthogonal acceleration region. This type of 
MS is known as orthogonal time-of-flight (oTOF).  In ion guiding steps preceding an oTOF 
component, ions travel in an axial direction towards the oTOF chamber, however they have a 
radial dimension, meaning at the moment of acceleration there is a distribution of kinetic 
energies causing some dispersion of the masses. A reflectron can be used to account for the 
distribution of kinetic energy during orthogonal acceleration and achieve a higher resolution.  A 
reflectron is a region of steady electric field in which ions of different energies will be reflected 
to the detector.  Ions with higher kinetic energies will travel further through the repulsive field 
correcting for the distribution of kinetic energy at the acceleration region, which standardizes the 
time-of-flight for molecules of the same mass. 
Many modern mass spectrometry systems are essentially hybrid systems consisting of multiple 
ion guides and mass filters.  The MS system in the Merritt laboratory in the Laurentian 
University Department of Chemistry & Biochemistry, for example, is a double-quadrupole time-
of-flight (qTOF) mass spectrometer. The qTOF includes ion capillaries, gates, double funnels, a 
hexapole, double quadrupoles, and finally an oTOF chamber.  Combining different MS systems 
provides better efficiencies and higher versatility.  For example, a qTOF MS is capable of 
tandem MS, in which parent ions can be fragmented into daughter ions to allow better 
identification of unknown molecules.  In tandem MS, ions enter the first quadrupole, which acts 
as either an ion guide in standard MS mode, or as a mass filter in tandem MS.  Ions that leave the 
first quadrupole then reach the second quadrupole, which also acts as an ion guide in standard 
MS mode, however can act as a collision cell in tandem MS (Verhoeven et al., 2006).  Following 
the quadrupole region of the MS, ions reach the TOF component, which is the main mass 
analyzer of the qTOF system.  
1.3.1 Electrospray ionization source 
There are several ionization sources available to introduce ions into the mass spectrometer 
depending on the preceding instrumentation; the most commonly used for broad scope 
metabolomic analysis include electron impact (EI), atmospheric pressure chemical ionization 
(APCI), and electrospray ionization (ESI) (Dettmer et al., 2007; Lee et al., 2010).  ESI is a “soft 
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ionization” technique that does not require the fragmentation of compounds before introduction 
into a mass spectrometer simplifying analysis.  Amongst all other ionization techniques ESI is 
capable of ionizing the broadest coverage of molecules for analysis (Wilm, 2011).  These 
characteristics make ESI ideal for metabolomic studies and are why ESI is used for this work. 
The exact ionization mechanism of ESI is currently unknown, however two of the most accepted 
models are the ion evaporation model (Iribarne and Thomson, 1976; Thomson and Iribarne, 
1979) and the charge residue model (Dole et al., 1968; Wilm and Mann, 1994).  In the ESI 
process a solution is sprayed from a capillary tube with an applied voltage and evaporated until 
the Raleigh limit is reached. The Raleigh limit is a situation in which an excess of ions lines the 
outer edge of a droplet and the surface charge density generates a surface tension equal to the 
coulombic repulsion of the ions (Wilm, 2011).  The two proposed mechanism of ESI differ after 
the Raleigh limit.  The ion evaporation model postulates that the molecular ion is expelled after 
the Raleigh limit is reached (Iribarne and Thomson, 1976; Thomson and Iribarne, 1979).  In 
contrast, the charge residue model postulates that the droplets continue to evaporate until a single 
ion is contained in a charged droplet and is finally expelled by evaporation and declustering 
(Dole et al., 1968; Wilm and Mann, 1994).  Regardless of the exact mechanism of ion formation, 
ESI is a highly versatile ionization source that is especially useful for metabolomic studies. 
ESI is a powerful tool in bioanalytical investigations, however the ionization efficiency of ESI 
can be drastically affected by complex sample matrices resulting in ion suppression (Müller et 
al., 2002).  Ion suppression occurs when multiple compounds exit an ESI source simultaneously 
affecting the ability of one, or more, of these molecules to ionize.  Ion suppression results in 
lower amounts of analytes entering a mass spectrometer and by association reduced signals.  The 
many compounds within complex matrices, such as biological metabolite extracts, are likely 
candidates for ion suppression and signals from such samples would likely be reduced if the 
complex matrices of compounds were not first separated before introduction into an ESI source.  
Several chromatographic separation techniques have been utilized in MS based metabolomics, 
however the three most common include gas chromatography (GC), capillary electrophoresis 
(CE), and high performance liquid chromatography (HPLC).  Each technique has its own 
strengths and weaknesses.  GC-MS and liquid chromatography (LC)-MS are often 
complementary techniques that can each resolve many compounds that cannot be resolved by the 
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other.  The limitations of GC-MS include a fewer number of compatible mobile phases, it is 
limited to volatile compounds unless complex derivatization steps are used, and it has limitations 
on the size and polarity of the molecules it can detect (Koek et al., 2011; Schauer et al., 2005).  
CE-MS protocols are robust, reproducible, and sensitive, however the method’s major limitation 
is a loading capacity of miniscule volume, a maximum of approximately 1µL.  This weakness, 
however, can be a strength when only small sample volumes are possible, including proteomic 
applications (Mischak et al., 2009).  Stringent sample preparation is necessary to accommodate 
the small loading capacity of CE, while LC based applications can be more forgiving.  The 
relative versatility of LC-MS based metabolomics makes it a good general choice and is why this 
technology was used for my thesis research. 
1.3.2 Column chemistry and ion pairing chromatography 
In general, HPLC works by separating compounds based on their ability to pass through, be 
retained, or slowed, by an adsorbent material.  Retaining compounds in LC is achieved by 
running a liquid sample over an adsorbent material (stationary phase) that is packed in a column, 
using a flow of solvent.  The compounds in the sample interact with the adsorbent material to 
different extents and escape the column (elute) at different times, depending on the strength of 
interactions.  The running solvent used for HPLC influences the retention of compounds.  
Parameters such as hydrophobicity, pH, ionic strength, and the temperature of the solvent all 
change the interactions of compounds with the adsorbent material.  The adsorbent material can 
be a polymeric, or granular, solid containing different chemical moieties, which will change the 
strength and types of interactions between the analytes, solvent, and adsorbent. 
The most widely used HPLC method is reversed phase (RP) C-18 chromatography, which uses a 
matrix of octadecyl silane (C-18) groups attached to free silanols as an adsorbent.  RP 
chromatography utilizes polar solvents to carry samples over the stationary phase, enabling 
molecules in the samples to interact with C-18 groups on the stationary phase.  Samples 
containing hydrophobic compounds will then adsorb to the hydrophobic alkyl chains of the 
column while polar compounds remain in the polar solvent.  Increasing the ratio of organic 
solutions (non-polar) to polar solutions in the running solvent will displace the adsorbed 
compounds from the column and the compounds will elute from the column. 
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C18 chromatography has many applications, but the technique was developed in an effort to 
analyze compounds of higher hydrophobicity (Vo Duy et al., 2012).  This makes the technique 
less than ideal for many biological applications in which analysis of small, polar, compounds is 
the goal.  An earlier form of LC columns used free silica particles in columns using a normal 
phase solvent condition.  Normal phase solvent conditions require a solvent with higher 
hydrophobic properties (Hydrophobicity: methanol < isopropanol < acetonitrile < heptane) to be 
used initially, in order to promote interaction of polar compounds with the stationary phase. The 
hydrophobic solvent is then replaced by an aqueous solvent, which will displace polar 
compounds interacting with silanols.  The interaction of polar molecules with free silanols is a 
multi-modal combination of hydrogen bonding, liquid-liquid partitioning, adsorption, and dipole 
interactions.  This type of chromatography was revisited in the 1990’s and renamed hydrophilic 
interaction chromatography (HILIC) (Alpert, 1990).  Since 1990, HILIC has been used 
extensively for analysis of small molecules with polar properties in a wide variety of applications 
(reviewed in: Buszewski and Noga, 2012).  
HILIC is a highly sensitive and versatile method of separation, but does have many shortcomings 
of its own.  Since HILIC is run in normal phase conditions, the initial solvent contains high 
proportions of acetonitrile, an aprotic (incapable of being a proton donor) solvent that limits the 
solubility of polar compounds.  Dissolving in higher proportions of aqueous solvent is 
detrimental to the efficiency of the chromatography because water acts as the strong solvent in 
HILIC, and sample composition should be similar to initial running solvent composition for all 
types of liquid chromatography (Layne et al., 2001).  HILIC is unable to resolve structural 
isomers such as glucose 6-phosphate and mannose 6-phosphate, although this is a failing 
common to most forms of chromatography (Bajad et al., 2006; Coulier et al., 2006; Luo et al., 
2007).  In order to re-equilibrate the silanol groups in HILIC columns with water, or “wet the 
column”, long equilibration times with a high proportion of acetonitrile are required (Buszewski 
and Noga, 2012).  In some cases long equilibration times can be an issue because of the high 
price of acetonitrile. 
Ion-pairing liquid chromatography (IP-LC) is an alternative separation technique for the analysis 
of polar molecules that avoids some of the limitations of HILIC.  This type of chromatography 
uses a hydrophobic stationary phase, such as a C18 column, in conjunction with an amphiphilic 
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ion.  Much like the mechanism of ESI, the exact mechanism of IPC is still a matter of debate, 
however proposed mechanisms include a combination of adsorption, ion-exchange, and 
electrostatic forces that exist between the amphiphilic ions, the column, and counter ions 
(Ståhlberg, 1999).  IP-LC is run under RP conditions, meaning solubility issues for polar 
molecules are avoided as they are dissolved in aqueous solvent (i.e. weaker mobile phase in RP).  
In several cases structural isomers, which cannot be separated by HILIC can be resolved using 
IP-LC (Coulier et al., 2006; Luo et al., 2007).  Like HILIC, IPC requires long equilibration 
times, although equilibrating in aqueous solvent rather than more expensive organic solvents 
alleviates some financial burden. 
1.4 Drosophila melanogaster:  Model for LC-MS analysis 
Drosophila melanogaster has served as a model species for studies in a wide variety of fields.  
Drosophila research has been taking place for over a century and through the organism’s use as a 
model species, many fundamental principles of genetics have been elucidated (Rubin and Lewis, 
2000).  The usefulness of D. melanogaster stems from many aspects of the species including the 
short-lifespan, manageable genome size, cheap and easy laboratory rearing requirements, and a 
plethora of genetic information and tools accumulated from over a century of research.  The near 
complete D. melanogaster genome was sequenced and annotated in 2000, setting the foundation 
for further functional genetic studies (Adams et al., 2000). 
To date, Drosophila genetics remains at the forefront of functional genomic studies and new 
molecular insights (Czech et al., 2013; Mackay et al., 2012).  Several levels of functional 
genomics have been extensively studied in Drosophila, including the transcriptome (Czech et al., 
2013; Graveley et al., 2011), and the proteome (Brunner et al., 2007; Chang et al., 2013).  
Metabolomics studies, however, have not seen wide-spread attention as in other systems, though 
new studies are beginning to emerge (Bratty et al., 2011; Kamleh et al., 2008; Passador-Gurgel et 
al., 2007; Sarup et al., 2012).  The relative scarcity of metabolomic Drosophila research leaves 
room for improved and standardized protocols, which have yet to be established.  Standardized 
protocols would facilitate the transition into metabolomics for new researchers, and promote the 
development of support systems for researchers interested in determining the identity of 
unknown compounds, and accessing protocols and results from other groups, much like support 
systems for other organisms (Bais et al., 2010; Cui et al., 2008; Wishart et al., 2013). 
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1.5 Reactive oxygen species and oxidative stress 
There are several intracellular molecules that are susceptible to oxidative damage by highly 
reactive chemical species, including reactive oxygen species (ROS) (Buonocore et al., 2010).  
ROS are generated as a result of aerobic metabolism and have vital roles in cell signaling, 
homeostasis, and microbial response (Buonocore et al., 2010).  ROS can also be generated from 
environmental factors such as exposure to radiation or foreign chemicals (Hosamani and 
Muralidhara, 2013; Riley, 1994).  While ROS are natural features in all biological systems, an 
excess of ROS concentrations can lead to rates of damage to lipids, DNA, proteins, and 
metabolites which cellular repair/turnover systems are inadequate to cope with.  Molecular 
damage thus accumulates, with deleterious effects on several biological processes and normal 
physiology. The altered state resulting from over exposure of oxidative damage from ROS is 
known as oxidative stress (OS).  An overabundance of ROS and conditions of OS are implicated 
in several degenerative diseases and disease states (Barber and Shaw, 2010; Dhalla et al., 2000).  
Though OS has been a major research interest for several decades, many processes are still not 
well understood and many avenues for research remain, LC-MS based metabolomics included.  
Organisms have multi-faceted antioxidant systems that neutralize the effects of ROS, however in 
conditions of overproduction or overexposure to ROS, the levels of ROS overwhelm an 
organism’s ability to counteract these cytotoxic molecules (Hosamani and Muralidhara, 2013; 
Riley, 1994). 
1.6 Superoxide dismutase 
Organisms have extensive antioxidant defense systems that limit the deleterious effects of ROS, 
including enzymatic and small molecule antioxidants.  In D. melanogaster, the cytosolic 
Superoxide dismutase 1 protein (SOD) is a major enzymatic antioxidant responsible for 
catalyzing the dismutation of superoxide into hydrogen peroxide.  Other antioxidant enzymes 
such as catalase or glutathione peroxidases then break down the hydrogen peroxide produced by 
SOD.  When SOD activity is lost in D. melanogaster, the ability of flies to remove free 
superoxide is reduced, and has been inferred to result in an accumulation of superoxide (Bernard 
et al., 2011; Phillips et al., 1989).  Higher concentrations of superoxide result in more oxidative 
damage to intracellular molecules, which leads to the condition of oxidative stress (Bernard et 
al., 2011; Phillips et al., 1989).  Physiological changes include reduced viability, drastically 
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reduced lifespan, sensitivity to ionizing radiation, sensitivity to superoxide generating chemical 
paraquat, and an overall enfeebled phenotype (Phillips et al., 1989).  In addition to loss of SOD 
activity being deleterious, under certain conditions over expression of the SOD enzyme can 
result in an increase in lifespan (Parkes et al., 1998a). 
The fly cytosolic Sod-null genotype, cSodn108, has been extensively characterized both 
genetically and physiologically (Bernard et al., 2011; Campbell et al., 1986; Parkes et al., 
1998b).  The genomic location of the Sod gene and its molecular details of the mutant allele are 
known.  One indication of the pleiotropic nature of SOD deficiency is that at a proteomic level, 
loss of SOD activity through the cSODn108 allele results in a general lowering of the activities of 
several enzymes involved in central carbon metabolism (Bernard et al., 2011).  The enzymes and 
metabolites assayed by Bernard et. al (2011) were chosen based on evidence from other studies 
that the processes these enzymes are involved in are affected by OS (Parkes et al., 1993; Ying, 
2008).  Despite choosing to assay down-stream phenotypes which were suggested to be altered 
by loss of SOD function some were not significant, or significant but subtle in magnitude, 
highlighting the unpredictability of pleiotropic genetic lesions (Bernard et al., 2011).  The 
unpredictability of downstream processes affected by pleiotropic genetic lesions makes these 
systems good candidates for untargeted, high throughput analysis, such as LC-MS based 
metabolomics. 
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Chapter 2 
2 A novel ion-pairing chromatography LC-MS metabolomics 
protocol for the study of biologically relevant polar metabolites 
We report a method of ion-pairing liquid chromatography coupled to mass spectrometry (IP-LC-
MS) that we have developed for the sensitive detection and quantification of a variety of 
biologically relevant polar molecules.  We use the ion-pairing agent diamyl ammonium (DAA) 
to improve chromatographic resolution of polar compounds, such as nucleotide cofactors, sugar 
phosphates, and organic acids, that are generally poorly retained by conventional reverse phase 
chromatographic methods.  This method showed good linearity (Average R value of 0.996) and 
reproducibility (generally RSD values <10%) with a set of prepared standards.  We demonstrate 
the utility of this method by investigating the metabolomic signature of three distinct biological 
systems: the metabolic response to lack of Superoxide dismutase activity and to paraquat 
induced oxidative stress, and the metabolic profiles of four different Drosophila species. 
2.1 Introduction 
Analysis of a broad suite of biologically relevant molecules, e.g. RNAs, proteins, or metabolites, 
is a central goal of many post-genomic era biological studies.  For example, the qualitative and 
quantitative study of all transcripts and protein in a biological system is the goal of 
transcriptomics and proteomics, respectively.  Similarly, metabolomic studies describe a 
comprehensive set of small molecule metabolites (Trethewey et al., 1999).  Comprehensive 
screening of transcripts and proteins is crucial in understanding complex biological processes, 
but stops short of describing the actual biology of the system.  In many cases, metabolites are the 
end products of these processes and understanding the metabolomic signature of a system can 
provide a more complete understanding of biological and biochemical processes (Fiehn, 2002).  
The metabolome is a highly complex and dynamic suite of molecules that can change in 
response to such factors as differences in gene activity (Reitman et al., 2011), various stresses 
(Smith et al., 2012; Wu et al., 2012), or xenobiotics (Giri et al., 2006).  Metabolomic profiling 
studies specifically characterize the changes or differences in the metabolome between 
conditions or genotypes.  This characterization is made challenging by the wide chemical 
diversity of metabolites.  This diversity is in contrast to that in genomics or transcriptomics in 
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which the nucleotide subunits share a similar biochemistry of interaction (i.e., Watson and Crick 
base pairing) and can all be identified and quantified with simple biochemical assays (nucleotide 
binding or synthesis).  Even the field of proteomics, in which the 20 amino acids are more 
complicated to assay than the four nucleotide bases, does not face the same chemical complexity 
of hundreds or even thousands of chemically distinct metabolites.  To analyze the entirety of the 
metabolome, multiple analytical platforms such as liquid chromatography-mass spectrometry 
(LC-MS), gas chromatography-mass spectrometry (GC-MS), or nuclear magnetic resonance 
spectrometry (NMR) are required, however an exhaustive survey is often technically or 
financially unfeasible.  A compromise is to use an individual platform with a broad coverage of 
metabolites that can present researchers with a reasonable understanding of biological processes 
in a reasonable time frame and at manageable cost.   
Mass spectrometry, combined with ultra-high performance liquid chromatography for sample 
separation, has been utilized in metabolomic studies for several years and can analyze a large set 
of polar to semi-nonpolar metabolites (Giri et al., 2006; Kristensen et al., 2012; Reitman et al., 
2011).  With effective sample preparation and chromatography, LC-MS strategies provide high 
sensitivity and specificity and a large dynamic range, advantages over some other metabolomic 
platforms.  In addition, LC-MS techniques are compatible with most standard solvents, avoid 
complicated derivatization steps, and can analyze larger polar molecules such as NADH, 
advantages over GC-MS based studies (Koek et al., 2011; Schauer et al., 2005). 
Broad metabolomic profiling is a developing field, and tested, widely applicable, protocols are 
still being developed.  Metabolomic profiling of Drosophila melanogaster by LC-MS is 
particularly rare, surprising given the central role of this species as a model system, although a 
few laboratories (Bratty et al., 2011; Chambers et al., 2012; Passador-Gurgel et al., 2007) have 
demonstrated the power of these studies in this system and more articles are beginning to be 
published (Cheng et al., 2013).  Reversed phase C18 chromatography (Chambers et al., 2012; 
Passador-Gurgel et al., 2007) and HILIC (Kamleh et al., 2008) have been utilized for profiling 
purposes however, the use of ion-pairing chromatography has yet to be explored.   
Effective chromatographic separation facilitates the generation of high quality LC-MS data.  The 
most common separation techniques for analysis of highly polar metabolites include Hydrophilic 
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Interaction Chromatography (HILIC) and Ion-pairing chromatography (IP-LC)(Cubbon et al., 
2010; Tolstikov and Fiehn, 2002).  Both techniques have advantages and disadvantages, which 
have been described in previous studies (Bajad et al., 2006).  In the last decade, the use of HILIC 
as a polar compound separation technique has increased drastically.  Unfortunately, HILIC can 
produce less than optimal peak shapes for many compounds including NADPH, NADH, and 
reduced thiols, and is generally unable to distinguish between structural isomers (Bajad et al., 
2006).  These compounds are central players in many biological systems including oxidative 
damage and stress and are of particular interest in our, and other, research group’s work (Bernard 
et al., 2011).  In addition, the reproducibility of HILIC can also be less than optimal: peak shape 
and retention time can be altered by subtle differences in temperature, pH, or solvent additive 
concentrations.  Ion-pairing chromatography, however, has been successfully employed to 
analyze many of the metabolites that we are interested in and avoids some of the limitations of 
HILIC, e.g. it often demonstrates greater reproducibility and better peak shapes (Luo et al., 
2007).  IPC has its own disadvantages, however, most notably ion-suppression, reduced 
sensitivity, and system contamination (Mallet et al., 2004).  In this paper we report a simple 
protocol for metabolomic analysis of polar metabolites using ion-pairing chromatography 
coupled to a qTOF mass spectrometer fitted with an Electrospray Ionization (ESI) source.   
To demonstrate the broad applicability of our protocol, we have used it to describe the 
metabolomic profile of three different biological systems: loss of cytosolic superoxide dismutase 
(cSOD) function, paraquat-induced oxidative stress, and the metabolomic profile of four 
different fly species (Diptera: Drosophila).  The superoxide dismutase protein (SOD) is a 
scavenger of reactive oxygen species (ROS) and loss of SOD function results in an accumulation 
of ROS, a state of chronic oxidative stress (Bernard et al., 2011; Campbell et al., 1986; Parkes et 
al., 1998b), and subsequent damage to the cell.  Paraquat is a powerful chemical oxidant once 
widely used as an herbicide, now commonly used to generate oxidative stress in experimental 
biological systems.  We use our protocol to determine the metabolomic profile of a Sod null 
mutant and chronic paraquat exposure induced oxidative stress in the model species Drosophila 
melanogaster.  Oxidative stress has broad and pronounced pathophysiological effects (James et 
al., 2004) and recent work, focused on specific metabolites, has shown significant changes in 
metabolite presence/absence and concentrations (James et al., 2004; Liu et al., 2011; Singh et al., 
2008).  Here we show that these metabolic effects are far-reaching.  We include our third 
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example, comparison of the metabolic profiles of D. melanogaster and three other cosmopolitan 
Drosophila species, to demonstrate the broad utility of our method across species boundaries.  
Different species, even four cosmopolitan species such as we have investigated, will have unique 
metabolic or physiological adaptations to their environments (Clark and Wang, 1994; Montooth 
et al., 2003).  Here we show distinct differences in the metabolic profile of these four Drosophila 
species, all collected from a single environment and maintained under identical laboratory 
conditions. 
We report here a versatile IP-LC-MS method for the simultaneous detection and quantification 
of hundreds of polar metabolites present in biological samples.  We use the volatile ion-pairing 
reagent (IPR), diamyl ammonium (DAA), to resolve the polar molecules on a classical reverse 
phase column.  Further, we demonstrate the utility of this method with examples from three 
distinct systems: a genetic knockout system, chemically induced oxidative stress and the 
metabolic characterization of four species on a common food.  This untargeted approach 
balances good analytical performance with a simple protocol and opens the door to metabolic 
characterization of other genetic systems and organisms. 
2.2 Materials and methods 
2.2.1 Chemicals and reagents 
All metabolite standards were obtained in high purity from Sigma Aldrich (St. Louis, MO) or 
Bioshop (Burlington, ON).  The ion-pairing reagent, diamyl ammonium (DAA) acetate, was 
purchased from TCI America (Product Number A5704, Portland, OR).  All solvents were high-
purity LC-MS grade and were obtained from Fisher Scientific (Sunnyvale, CA). 
2.2.2 Fly stocks 
Superoxide dismutase mutant: Details of the D. melanogaster Sod1- null and Sod+ control alleles 
have been described in earlier studies (Bernard et al., 2011; Campbell et al., 1986).  Briefly, the 
D. melanogaster Sod1- null allele, cSODn108, has essentially no SOD activity (Campbell et al., 
1986).  The Sod+ control genotype is a whole organism transgenic rescue line (w+; T5/T5; 
cSODn108red/TM3) that was constructed in the same genetic background as the null, but has a 
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second chromosome SOD transgene under the control of the native Sod1 promoter resulting in 
flies with approximately 50-60% of wildtype SOD1 activity (Parkes et al., 1998b).  Despite the 
lower than wildtype activity, the T5 line is generally phenotypically indistinguishable from wild-
type (Parkes et al., 1998b), and, as such, is used as a control.   
Multiple Drosophila species: All fly lines were isofemale lines, lab cultures established from 
single wild-caught females, and were established from a compost heap in Sudbury, Ontario, 
Canada, in late July 2013.  Three isofemale lines of D. melanogaster were identified 
morphologically.  Three isofemale lines of D. immigrans, and D. busckii, and one isofemale line 
of D. hydei were identified morphologically and species identification confirmed by comparison 
of the “barcode” fragment of the COI gene (Goto and Kimura, 2001) with reference sequences in 
Genbank. 
In all application examples, multiple samples of multiple flies were collected to account for fly-
to-fly, and vial-to-vial, variation.  Multiple vials were used to collect up to 15 flies.  If 15 flies 
could not be collected, then the homogenization buffer was reduced accordingly.  In the Sod 
experiment, we assayed 56 Sod+ and 56 Sod1- samples and 31 quality control (QC) injections, 
which consisted of a pooled mixture from extracts of both sample types.  In the paraquat 
experiment, we assayed 20 paraquat treated T5 control samples and 20 T5 control samples (no 
paraquat), and 30 QC samples.  In the metabolomic comparison across species, we assayed four 
samples from three isofemale lines of D. melanogaster, D. busckii, and D. immigrans, and four 
samples of one isofemale D. hydei line and 15 QC samples. 
2.2.3 Culture conditions 
Flies were maintained on a standard cornmeal-yeast-agar media (Sod and paraquat experiment) 
or Carolina Biological (Burlington, North Carolina) Formula 4-24 instant Drosophila medium 
(cross-species comparison) at 25 oC with a 12-hr/12-hr photocycle.  For metabolomic profiling, 
groups of ten male, and ten female, Drosophila were placed in vials containing the appropriate 
medium and allowed to lay eggs for 5 days.  Non-virgin adult male progeny of the desired 
genotype were collected and aged 3-4 days post-eclosure.  After aging, flies were anesthetised 
and collected in groups of 15 flies, flash frozen in liquid nitrogen, and stored at -80 oC until 
further processing.  Liquid nitrogen was used to quench metabolism and storage in -80 oC was 
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used to prevent degradation before analysis; techniques used with biological samples (Lu et al., 
2008; Want et al., 2013). 
2.2.4 Chemically induced oxidative stress 
The Sod+ T5 control line was utilized to metabolically assess the effect of paraquat induced 
stress by LC-MS analysis to allow more direct comparison of the results of this experiment to 
those of the Sod-null experiment.  T5 flies were raised (as described above) in either standard 
cornmeal-yeast-agar media (control) or on the same medium treated to a final concentration of 
0.5 mM paraquat (Rzezniczak et al., 2011).  Non-virgin males that developed in paraquat treated 
medium were transferred to fresh paraquat treated medium on the day of eclosion and allowed to 
age for two more days before being flash frozen in liquid nitrogen and stored at -80OC until 
further processing. 
2.2.5 Sample preparation 
The weight of individual flies often varies within, or between cultures, and can vary drastically 
across species.  To account for differences in the amount of tissue between fly collections, we 
standardized the volume of extraction solvent to wet mass of the flies in each sample.  All fly 
samples were weighed to the nearest 0.01mg with a microbalance (MX5 Balance, Mettler Toledo 
AG, Greifensee Switzerland).  A volume of 6.35 µL/mg was used for Sod-null and paraquat 
stress experiments.  Due to the relative difficulty in maintaining some Drosophila species under 
laboratory conditions, smaller sample sizes (fewer flies) were used for the multi-species 
comparison.  Fewer flies per sample necessitated a larger extraction volume, 10 µL/mg, to 
achieve the minimum volume required for the assays.  Metabolites were extracted from fly 
samples as follows.  Samples were homogenized in extraction solvent (3:1:1 
methanol:water:chloroform) in a mixer mill (TissueLyser, Qiagen) using 3.5mm stainless steel 
beads in 1.5 mL microcentrifuge tubes with screw caps at 30 Hz for one minute.  Sample tubes 
were centrifuged at 13000 x g for 10 minutes at 4°C to pellet solids and 20 µL of homogenate 
was diluted in 60 µL of 10 mM DAA at pH 4.95 (Solvent A, see below).  For quality control, 
homogenate from control and experimental, or from all four Drosophila species, were pooled 
and assayed at various points during analysis. 
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2.2.6 Instrumentation 
All experiments were carried out on a Dionex UltiMate 3000 Rapid Separation LC system 
(Thermo Scientific, Sunnyvale CA) coupled to a Bruker micrOTOF-Q II™ electospray 
ionization-quadrupole-time of flight mass spectrometer (Bruker Daltonics, Billerica MA).  The 
MS was operated in negative mode and was calibrated using sodium formate dissolved in 
water/isopropyl alcohol, infused at a flow rate of 0.18mL/hour using a KD Scientific 100L 
infusion pump.  The ionization source working parameters were as follows: capillary voltage 
4kV, ion energy of quadrupole 4eV/z, dry temperature 200°C, nebulizer 4.0 bar, and dry gas 9.0 
L/min.  Chromatographic separation was achieved at 0.400 mL/min using a Kinetex C18 RP 100 
mm x 2.1mm I.D., 1.7 µm particle size, 100 Å pore size, column (Phenomenex, Torrance CA) at 
50°C with eluent A (10mM diamylammonium acetate aqueous solution adjusted to pH 4.95 with 
acetic acid) and eluent B (methanol) following the gradient described in Table 1. 
2.2.7 Data analysis 
Data was acquired using the Hystar 3.2 software package and evaluated using Compass 
DataAnalysis 4.0 software package (Bruker Daltonics, Billerica MA).  Principal component 
analysis (PCA) and t-tests were performed using ProfileAnalysis 2.0 software (Bruker Daltonics, 
Billerica MA), and standard curves were generated using QuantAnalysis software (Bruker 
Daltonics, Billerica MA).  Metabolite peaks were detected and time aligned using the Find 
molecular features function (FMF) in DataAnalysis software works in conjunction with the 
ProfileAnalysis software.  The analysis window used in these analyses commenced after the void 
and calibration segment (0.4 minutes), and stopped before the high organic washing step that 
reached the mass spectrometer at 24 minutes.  Features were represented as buckets, consisting 
of a mass to charge ratio (m/z) and a retention time.  Each bucket was normalized by the sum of 
all buckets in the analysis and Pareto scaling was used.  Bucket intensity values of the top 30 
features, ranked by T-test/ANOVA, were exported into MetaboAnalyst software 
(http://www.metaboanalyst.ca/MetaboAnalyst/faces/Home.jsp)(Xia et al., 2009, 2012), which 
was used for hierarchical clustering using a Spearman rank correlation and an average clustering 
algorithm. 
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2.2.8 Quantification and Validation procedure 
2.2.8.1. Ion suppression 
Ion suppression was quantified by comparing metabolite signal intensities between clean solvent 
conditions and pH adjusted solvent with DAA.  Briefly, six candidate metabolites were chosen 
from each LC gradient (ATP – eluting at 40% Solvent A, ADP – eluting at 65% Solvent A, 
Arginine – eluting at 95% Solvent A, GSH – eluting at 90% Solvent A, Succinate – eluting at 
80% Solvent A, NAD – eluting at 85% Solvent A).  Standard solutions at 5ppm were made and 
these metabolites were individually directly injected into the ionization source using the LC 
injector, i.e. no LC column was used.  The mobile phase was isocratic, with the percentage of 
Solvent B adjusted to reflect the gradient at which the metabolites elute when a column is used. 
2.2.8.2. Matrix effects 
We quantified potential matrix effects of fly homogenate using the post-extraction spike method 
(Matuszewski et al., 1998).  Flies were collected and homogenized and the homogenate was 
divided into subsets: one subset (homogenate only) was used to determine the MS response from 
the metabolites in fly homogenate and the other subset was spiked with 5 ppm of standard. Both 
subsets were analyzed by LC–MS as described above and the peak area of metabolite in the fly 
was subtracted from the peak area found in the spiked sample to correct for naturally-occurring 
concentrations of the metabolite in the fly. Candidate metabolites were selected as described for 
our testing of ion suppression (above). Corrected peak areas from spiked homogenate were then 
compared with peak areas from metabolite run in clean solvent (i.e., LC–MS grade water) to 
determine the matrix effects of the fly homogenate. 
2.2.8.3. Limits of detection/linearity 
The calibration curve for 41 metabolites was obtained by analyzing standard solutions at ten 
concentrations: 50, 65, 85, 100, 500, 1000, 5000, 10000, 50000, and 100000 ppb.  Calibration 
curves were generated using QuantAnalysis software (Bruker Daltonics, Billerica MA), which 
plots the area under the curve (AUC) against the concentration of the compound.  Linear 
regressions were used and linearity was calculated from these curves.  Limits of quantification 
(LOQ) and the limits of detection (LOD) were calculated for each metabolite. 
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2.3 Results and discussion 
2.3.1 Method development 
We have developed an ion-pairing chromatography method that resolves many polar compounds 
not well retained by typical chromatographic methods for use as part of a liquid chromatography 
– mass spectrometry protocol.  Method development was performed by injecting prepared 
standard solutions of commercially available chemicals.  Metabolite identification in flies was 
performed by comparing mass to charge ratios and retention times with prepared standards, and 
confirmed by injection of spiked homogenate solutions.  We initially tested the resolving 
capabilities of reversed phase (RP) C-18 and similar column chemistries for a set of target polar 
compounds, but found that the polar compounds all eluted at, or near, the void volume (data not 
shown).  While ion-pairing reagents (IPRs) are expected to improve retention of polar 
compounds, they may cause ion suppression, adduct formation, and MS source contamination 
(Hsieh et al., 2001; Luo et al., 2007).  In an effort to avoid these issues, while gaining the longer 
retention times, characteristic of IPRs, we examined the utility of the volatile IPR diamyl 
ammonium.  To our knowledge, the use of this agent in an LC/MS protocol has not previously 
been investigated, in particular for metabolic profiling workflows. 
DAA acetate is a secondary ammonium salt with two amyl side chains that allow for interactions 
with C-18 carbons.  DAA is less hydrophobic than quaternary and tertiary alkyl ammonium salts, 
traditional IPRs, yet yields acceptable retention of acidic-polar compounds (Fig. 1).  In 
particular, phosphorylated nucleotide cofactors which are difficult to analyze using RP and 
HILIC (Bajad et al., 2006), had excellent retention with our protocol (Metabolites 27, 39-40 Fig. 
1).  Under acidic conditions reduced forms of nucleotide cofactors are unstable, however the 
moderate pH used in this protocol does not result in observable degradation of these compounds 
(Luo et al., 2007).  With regular care and attention, DAA can be relatively easily cleaned from 
the LC/MS system.  DAA is virtually undetectable following four hours of direct injection of 
clean solvent and an acid wash of the LC unit using a water/organic solution of 100mM sodium 
perchlorate and 0.1% (w/v) phosphoric acid (results not shown).  It is worth stressing, however, 
that this cleaning should be regular.  We have found that even this ion-pairing agent can become 
harder to remove if the system is run too long (weeks) without a regular cleaning. 
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Figure 1: Combined extracted peak chromatograms of prepared standards in solution 
using solvent A.  Peaks represent specific metabolites and numbers over peaks correspond to 
metabolites in Table 2. 
The optimum pH for separation of a wide range of metabolites using the IPR tributylamine 
(TBA) has previously been determined to be 4.95 by Luo et al. (Luo et al., 2007).  Considering 
the similar pKa values of TBA and DAA and the use of the same acetic acid buffer, we adjusted 
our DAA solution to a pH of 4.95.  Similarly, the LC gradient utilized was adapted from Luo et 
al. (Luo et al., 2007) with the time adjusted to account for differences in column dimensions. 
Table 1: Liquid chromatography gradient 
Step Total Time (min) Eluent A (%) Eluent B (%) 
1 1.25 95 5 
2 5.25 80 20 
3 15.25 80 20 
4 17.50 65 35 
5 19.25 65 35 
6 21.00 40 60 
7 22.75 40 60 
8 22.85 10 90 
9 24.50 10 90 
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10 24.60 95 5 
11 31.50 95 5 
 
2.3.2 Ion suppression/enhancement 
We observed both ion enhancement and suppression by DAA (Fig. 2).  The level of ion 
suppression or enhancement across the LC gradient was estimated by comparing the signal 
strength of six different metabolites injected with clean solvent to that strength when injected 
with solvent containing DAA.  At high DAA content (i.e., when the LC gradient contained 
greater than 95% solvent A), we observed a 49.5% signal decrease for arginine (Fig. 2B, 
F1,5=23.53, P < 0.0167) and a decrease of 25% for succinate (Fig. 2B, F1,5=419.73,  P < 0.0003) .  
This suppression is substantially lower than that with traditionally used ion-pairing reagents.  Ion 
suppression with trifluoroacetic acid (TFA), for example, averaged 87% under similar conditions 
(Mallet et al., 2004b).  We observed ion enhancement for the remaining tested metabolites (GSH, 
NAD, ADP & ATP; see Fig. 2A and 2B).  The ion enhancement caused by DAA for GSH and 
NAD was relatively small with signal increases of 3.9% (F1,5 = 10.30, P < 0.0490)  and 34.8% 
(F1,5 = 153.39, P < 0.0011) respectively.  On the other hand, when the LC gradient contained less 
DAA (i.e., 40 – 65% DAA Solvent) the ion enhancement observed was much greater: a 94.4% 
increase in the signal of ADP (F1,5 = 619.5, P < 0.0001) and a 2328.0% increase in ATP signal 
(F1,5 = 4137, P < 0.0001).  Nucleotide cofactors were used to estimate ion 
suppression/enhancement at lower levels of DAA, because these were the only compounds in the 
standards that we assayed that elute at higher organic solvent concentrations.  Ion suppression or 
enhancement from solvent conditions is compound specific and the values obtained in this study 
are used for a rough estimate of overall values.  The high level of ion enhancement for ATP and 
ADP could be a result of the chemical properties of the compounds, and other compounds that 
elute at, or near, the same time may be affected differently by DAA in the solvent. 
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2.3.3 Matrix effects 
Our protocol is intended for fast and simple analysis of a wide variety of compounds.  To 
minimize time, cost, and the potential loss of some metabolites (e.g. through retention on Solid 
Phase Extraction columns), we included a minimum of sample preparation and clean up.  The 
quick protocol allows for the processing of many samples in a short period of time, but the 
relatively “dirty” sample homogenate may impact resolution of some metabolites.  The 
simplicity of our sample preparation protocol leaves analyses susceptible to ion suppression from 
phospholipids and/or co-eluting compounds, i.e. matrix effects (Müller et al., 2002).  To address 
the extent of this potential problem, we quantified matrix effects by comparing the signal 
intensities of candidate metabolites in “clean” solution to the standards in complex fly 
homogenate (Fig. 3).  Of the five tested candidate metabolites, two metabolites (glycerol-1-
phosphate and tryptophan) did not have any significant matrix effects, while three metabolites 
(arginine, succinate, and aspartate) had significant positive or negative effects.  Signal intensity 
was suppressed in fly matrix by 59.6% for arginine and by 50% for succinate and enhanced by 
31% for aspartate (Fig. 3; F1,5 = 26.104, P > 0.0069; F1,5 = 85.710, P > 0.0008; F1,5 = 227.522, P 
> 0.0001, respectively).  Although matrix effects were relatively high for some compounds 
(arginine and succinate), they were within acceptable range based on current opinion for a 
untargeted, whole-metabolome approach (Böttcher et al., 2007).  More thorough sample clean up 
may reduce such matrix effects, but runs the risk of also removing metabolites.  We suggest that 
researchers should weigh these pros and cons on a case-by-case basis. 
 24 
 
Figure 2: Ion suppression/enhancement caused by the ion-pairing reagent, DAA.  Signal 
intensities, measured through area under the curve (AUC), for candidate metabolites, were 
quantified in the absence of DAA (black bars), and in the presence of DAA (grey bars).  Changes 
in the signal intensities are shown for (A) the nucleoside phosphates: adenine 5’-triphosphate 
(ATP) and adenosine 5’-diphosphate (ADP), and for (B) reduced glutathione (GSH), arginine, 
nicotinamide adenine dinucleotide (NAD), and succinate.  Overall, the compounds show lower 
ion suppression than traditional ion-pairing reagents (data not shown). 
 25 
 
Figure 3: Matrix effects in Drosophila homogenate.  The amount of ion suppression or 
enhancement caused by fruit fly homogenate was quantified using the post-extraction addition 
method.  Matrix effects were quantified for candidate metabolites by the area under the curve 
(AUC) for each metabolite, at a concentrations of 5 ppm, in clean solution, which consisted of 
mobile phase (black bar) and 5 ppm of metabolite spiked into fly homogenate (grey bar) after 
correcting for the amount of metabolite in the homogenate alone. 
2.3.4 Linearity and quantification 
Calibration curves were determined for 41 metabolites using 10 µL injections of concentrations 
ranging from 0.050 ppm to 100 ppm.  In general, the metabolites showed excellent linearity over 
three or greater orders of magnitude, with correlations coefficients (R2) of ≥ 0.95.  On average, 
the LOD and LOQ were comparable to those found in previous studies (van Dam et al., 2002; 
Huck et al., 2003; Soga et al., 2009), but were approximately an order of magnitude greater than 
those found by Luo et al. (2007).  The difference in these values may be due to the nature of the 
different IPR in either study.  The LOD and LOQ were higher for certain metabolites including 
ADP, AMP, ATP, malate, NADH, NADP and NADPH. 
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Table 2: Retention times, linearity of calibration, limits of detection and limits of 
quantification 
Compound Retention time (min) 
Linearity 
LOD (ppm) LOQ (ppm) 
Range (ppm) R2 
1 Ornithine 0.46 0.5 - 100 0.996   
2 Lysine 0.46 0.5 - 50 0.998 0.298 0.996 
3 Arginine 0.47 0.5-10 0.999 0.288 0.960 
4 Dopamine 0.50 5-100 0.997 0.184 0.613 
5 Histidine 0.51 0.085 - 5 0.998 0.025 0.082 
6 Asparagine 0.55 0.1 – 10 0.978 0.100 0.653 
7 Glutamine 0.55 0.1 - 100 0.995 0.100 0.423 
8 Threonine 0.55 0.85-10 0.999 0.396 1.319 
9 Serine 0.56 0.5 -10 0.996 0.153 0.508 
10 Trehalose 0.56 0.5 -100 0.999 0.383 1.277 
11 Proline 0.58 0.5 - 100 0.999 0.486 1.620 
12 Cysteine 0.59 5-50 1.000   
13 Valine 0.62 0.5-100 0.993 0.476 1.587 
14 Methionine 0.68 0.05 - 100 0.989 0.050 0.445 
15 Tyrosine 0.76 0.05 - 100 0.998 0.050 1.015 
16 Leucine 0.82 0.085 - 50 0.997 0.085 0.660 
17 Phenylalanine 1.20 0.085 - 10 0.995 0.085 0.504 
18 Glutamate 1.33 0.05 - 10 0.984 0.050 0.312 
19 Aspartate 1.41 0.05-10 0.992 0.050 0.356 
20 CDP-Choline 1.81 0.5 - 100 0.998 0.359 1.196 
21 Tryptophan 1.89 0.5 - 100 0.999 0.210 0.700 
22 Glucose-6-Phosphate 2.33 10 - 100 0.999 1.772 5.908 
23 Pyroglutamate 2.42 0.05-10 0.999 0.022 0.072 
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Compound Retention time (min) 
Linearity 
LOD (ppm) LOQ (ppm) 
Range (ppm) R2 
24 Glycerol-1-Phosphate 2.48 0.5 - 50 0.999 0.500 1.867 
25 Glutathione (reduced) 2.85 0.1 – 100 0.999 0.100 1.400 
26 β-glycerophosphate 2.87 0.5 - 100 0.995 0.281 0.935 
27 NAD+ 4.47 0.5 - 100 0.999 0.500 2.834 
28 AMP 6.01 5 - 100 0.997 5 25.107 
29 Succinate 6.07 0.05 -100 0.993 0.050 2.948 
30 Malate 7.04 5 - 100 0.993 3.054 10.182 
31 Glutathione (oxidized) 7.87 0.5-50 0.998 0.500 1.690 
32 α-Ketoglutarate 8.35 1 - 100 0.999 0.231 0.771 
33 6-phosphoglucanate 9.04 5-100 0.999 0.620 2.066 
34 Fumarate 9.18 0.5 - 50 0.996 0.500 6.531 
35 Fructose-1,6-Bisphosphate 11.15 10 – 100 0.999 0.859 2.862 
36 Phosphoenol pyruvate 12.67 1-50 0.996 0.509 1.700 
37 NADP+ 13.60 10 - 100 0.999 6.706 22.353 
38 ADP 17.53 10 - 100 0.982 10 43.648 
39 NADH 18.02 5 –50 0.999 5 20.663 
40 NADPH 21.31 10 – 100 1.00 2.948 9.829 
41 ATP 21.53 10 - 100 0.998 10 65.153 
 
2.3.5 Reproducibility 
Across the triplicate injections, the relative standard deviations (RSD) of the peak area for 5 ppm 
and 50 ppm injections were used to assay intra-day variation for all metabolites listed in table 2.  
Inter-day variation was assessed using 5ppm and 50 ppm injections in triplicate over three days 
for a subset of 10 metabolites.  In general, the RSD of metabolites are below 15 %, which are 
comparable to similar IPR and HILIC methods (Bajad et al., 2006; Coulier et al., 2006; Luo et 
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al., 2007).  The first 16 metabolites elute quickly, at or near the void volume, potentially leading 
to poor reproducibility of their identification and quantification.  To address the issue of 
reproducibility, we performed a spike-in experiment with these 16 metabolites at 3 different 
concentrations.  For each of the three concentrations, all 16 standards were spiked into fly 
homogenate (to account for possible matrix effects) and 5 replicates run through our LC/MS 
protocol. The standards injected in combination showed good reproducibility across all three 
concentrations, although methionine, valine, and dopamine demonstrate reduced stability in 
signal at lower concentrations (Appendix D).  The intra-day reproducibility for the majority of 
compounds fall below 15%, a criterion previously applied by the Food and Drug Administration 
(FDA) which is followed by other bioanalytical studies, although an RSD of up to 20% is 
acceptable for low intensity signals (Center for Drug Evaluation and Research (CDER) and Food 
and Drug Adminstration (FDA), 2001; Dunn et al., 2008; Gika et al., 2007). The low RSD values 
indicate that our method is reproducible even in this short retention time region. 
Table 3: Reproducibility of LC-MS signals 
Compound Retention time (min) 
Intra-Day Reproducibility Inter-Day Reproducibility 
50ppm 5ppm 50ppm 5ppm 
1 Ornithine 0.46 1.78 4.26   
2 Lysine 0.46 2.61 2.93 9.18 11.36 
3 Arginine 0.47 0.568 2.19   
4 Dopamine 0.50 1.43 3.54   
5 Histidine 0.51 1.20 1.58   
6 Asparagine 0.55 1.77 1.41   
7 Glutamine 0.55 0.42 8.43   
8 Threonine 0.55 2.36 4.91   
9 Serine 0.56 NA 4.52   
10 Trehalose 0.56 2.08 11.51   
11 Proline 0.58 0.84 5.76   
12 Cysteine 0.59 2.77 8.25   
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Compound Retention time (min) 
Intra-Day Reproducibility Inter-Day Reproducibility 
50ppm 5ppm 50ppm 5ppm 
13 Valine 0.62 0.381 1.46   
14 Methionine 0.68 1.51 4.45   
15 Tyrosine 0.76 2.02 3.85   
16 Leucine 0.82 1.89 5.47 0.03  
17 Phenylalanine 1.20 5.53 1.66 0.47  
18 Glutamate 1.33 NA 2.02   
19 Aspartate 1.41 1.43 2.21   
20 CDP-Choline 1.81 1.65 0.995   
21 Tryptophan 1.89 0.58 4.30 8.15 13.70 
22 Glucose-6-Phosphate 2.33 17.68 7.97 16.43 2.99 
23 Pyroglutamate 2.42 2.59 3.18   
24 Glycerol-1-Phosphate 2.48 0.619 9.97   
25 Glutathione (reduced) 2.85 2.05 3.94   
26 β-glycerophosphate 2.87 1.52 2.11   
27 NAD+ 4.47 1.95 3.86 12.48 16.72 
28 AMP 6.01 5.16 48.28 8.53  
29 Succinate 6.07 1.42 0.288   
30 Malate 7.04 3.60 12.06   
31 Glutathione (oxidized) 7.87     
32 α-Ketoglutarate 8.35 2.80 35.98   
33 6-phosphoglucanate 9.04 0.757 0.411   
34 Fumarate 9.18 0.918 1.32   
35 Fructose-1,6-Bisphosphate 11.15 4.03 NA   
36 Phosphoenol pyruvate 12.67 2.91 5.56   
37 NADP+ 13.60 2.38 NA   
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Compound Retention time (min) 
Intra-Day Reproducibility Inter-Day Reproducibility 
50ppm 5ppm 50ppm 5ppm 
38 ADP 17.53 16.8 7.33 6.88 18.92 
39 NADH 18.02 26.03 25.08   
40 NADPH 21.31 4.03 NA   
41 ATP 21.53 12.49 NA 13.77  
 
2.3.6 Application 
We assessed the general applicability of our LC-MS protocol to variety biological questions by 
using it to determine the general metabolic profile of three diverse systems: loss of cytosolic 
SOD function, the effect of chemical-induced oxidative stress, and the metabolite profiles of four 
different fly species. 
2.3.7 The effect of loss of cytosolic Superoxide dismutase function 
Loss of SOD function results in a pronounced and widespread effect on the metabolome: almost 
one third of the features differ in concentration between Sod-null and control flies.  We detected 
594 putative metabolites (automatically extracted features) within our analysis window and of 
these, 168 (28%) features had significantly different concentrations between Sod-nulls and 
controls using an uncorrected P-value cut-off of 0.05, 138 using a value of P ≤ 0.01.  Clustering 
of the top 30 significantly regulated features clearly resolves the Sod- and Sod+ flies (Fig. 4).  In 
Fig. 4 it is apparent that there is variation in biological response between samples, which is 
expected in biological systems (Bernard et al., 2011; Merritt et al., 2005; Rzezniczak and Merritt, 
2012), and highlights the need for replication in the experimental design.  Principal Component 
Analysis (PCA) also captures the impact of loss of SOD function on the metabolome (Fig. 5).  
Sod1- lines differed from controls along principal component 1 (PC1), which captured 15.8% of 
variation.  Several features, including glutamine and C15H20O11, that drive variation along PC1 in 
Fig. 5 also contribute to the separate clustering of Sod1- and Sod+ genotypes in Fig. 4.  The fact 
that many of the metabolite differences are statistically robust, but of relatively small absolute 
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magnitude, strongly suggests that biological replication is absolutely crucial in capturing trends 
that are variable yet biologically interesting.  In addition to subtle differences, there are also 
many features with distinct and pronounced differences between null and control that show 
limited variability between samples.  Given the central role of the SOD protein in the fly 
(Campbell et al., 1986), the distinct metabolic signature between null and control was expected, 
but the scope of the difference, almost one third of features differing, is striking.  The relatively 
small differences in fold change are a function of the biology of this system – many biologically 
interesting differences are of small absolute magnitude – not the protocol we have developed. 
The ability of our protocol to resolve these small differences in biological responses is an 
advantage of untargeted mass spectrometry based metabolomic techniques (Weckwerth et al., 
2004).   
The group of metabolites that significantly differed between the Sod- and Sod+ flies included 
both identified and unidentified metabolites.  Eighteen of the 45 metabolites we used in 
optimizing the protocol differed significantly in concentration between the null and control flies; 
the remaining metabolites have not yet been identified.  Fig. 8A shows the difference in 
concentration of three representative metabolites: glutamine, oxidized glutathione, and the 
unknown metabolite with a predicted molecular formula (C15H20O11). 
2.3.8 The effect of paraquat induced stress 
PQ-induced oxidative stress also had a pronounced effect across the metabolome, although not as 
widespread as that of loss of SOD activity.  We identified 459 common features, 59 of which had 
significantly different concentrations between experimental and control samples using a P < 
0.05, 40 features differ using P < 0.01.  The metabolite profiles of the top 30 features, ranked by 
t-test, cluster the treated and control samples separately, as depicted in the heat map (Fig.  6). 
uaThe differences in the metabolic profiles of treated and control flies are also reflected in PCA 
(Appendix A).  The stressed samples could be distinguished on PC2, which together with PC1 
captures 28.2% of the variation.  Fig. 8B shows three representative metabolites that differ 
between treated flies and controls: glutamine and two unidentified compounds with predicted 
molecular formulas of (C9H16NO5) and (C6H12O7). 
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Figure 4: Heat map of metabolite profiles for the top 30 significantly different metabolites 
for Sod-nulls vs. T5 control lines.  The level of each compound (x-axis) in each sample (y-axis) 
is represented as the fold change above the mean level of that compound.  Along either axis, the 
compounds and samples are arranged by unsupervised hierarchical clustering. 
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Figure 5: Principal component analysis (PCA) loadings and score plots representing the 
metabolic profiles of the Sod-nulls vs. T5 control lines.  Quality control (QC) injections are 
included in the plot.  Axes represent principal component one (PC1) and principal component 
two (PC2) for both loadings and score plots. 
Loss of SOD activity and paraquat treatment have been proposed to both create a condition of 
chronic oxidative stress (Bernard et al., 2011; Rzezniczak et al., 2011).  Given this prediction, it 
is interesting to compare our metabolomic signature of loss of SOD activity with that of PQ-
induced oxidative stress.  Both sources of oxidative stress resulted in broad metabolic changes 
(Fig. 4 and 5).  While the majority of metabolite differences in response to loss of SOD activity 
or paraquat stress were specific to either system, 18 putative metabolites did show similar 
responses to either stressor.  Presumably, the shared responses reflect the general condition of 
oxidative stress while the differences reflect the different mechanism of stress (genetic versus 
chemical) and other unique features of each treatment.  For example, glutamine concentration 
was higher in both genetically and chemically stressed flies (Sod-nulls 1.42 fold, P = 2.54e-22; 
Paraquat treatment 1.90fold, P = 6.56e-10; fig. 8A and B).  Glutamine is an important 
intermediate in nucleotide synthesis (Neu et al., 1996), provides a source of energy when 
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glycolysis is shunted for other purposes or the electron transport chain is disrupted (Piva and 
Mcevoy-Bowe, 1998), and is involved in anti-apoptotic (Matés et al., 2002) and autophagic 
(Jardon et al., 2012) signaling.  All of these functions can be responses to oxidative stress.  
Glutamine is also a precursor to the tri-peptide anti-oxidant, glutathione (GSH), which reduces 
ROS and becomes an oxidized dimer (GSSG) (Matés et al., 2002).  GSH is a major antioxidant 
component of biological systems and is elevated in paraquat treated flies (1.31 fold, P = 8.87e-
8).  In contrast, GSSG was detected at higher levels in the Sod-null genotype compared to 
controls (1.48 fold, P = 3.02e-6) while GSH levels remained the same.  These commonalities and 
differences in metabolome response are the focus of an ongoing investigation of oxidative stress 
in D. melanogaster in the Merritt Laboratory. 
2.3.9 Species specific metabolic signature 
As a test of the broad applicability of our protocol to general systems beyond oxidative stress and 
D. melanogaster, we compared the metabolite profiles of four Drosophila species collected from 
the wild and reared on a common diet:  D. melanogaster, D. hydei, D. immigrans, and D. busckii.  
Diet can have a pronounced impact on an organism’s metabolome (e.g. Matzkin et al., 2011, 
2013).  Given that different species can have different metabolic requirements or optima (e.g. 
(Matzkin et al., 2011) we tested to see if we could resolve the different metabolic signatures from 
species raised on a common laboratory food.  Species were chosen that occupy a similar “wild” 
environment (a local compost heap) and lines were chosen that had similar, short, laboratory 
histories to avoid potential differences in adaptation to the laboratory and media (e.g. Orozco-
terWengel et al., 2012).  In this experiment, we detected 650 putative metabolites within our 
analysis window.  All four species are clearly resolved by clustering of the top 30 metabolites 
determined by ANOVA (Fig. 7).  D. melanogaster and D. busckii are resolved, between 
themselves, and between D. hydei and D. immigrans, which share similar global metabolic 
profiles, determined by PCA (Appendix B).  Many features were detected at different levels 
between species.  Thirty of these are represented in Fig. 7 and three that differentiate between 
species are represented in Fig 8c.  Pyroglutamate was detected at higher levels in Drosophila 
busckii than in all other Drosophila species.  The unknown feature at (C16H24N5O10) was higher 
in D. immigrans compared to D. melanogaster and D. busckii, however was not statistically 
different from D. hydei.  Interestingly, the unknown feature C15H20O11 was not only higher in D. 
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melanogaster than all other species but was also a distinguishing feature of the Sod-null 
genotype.  D. hydei did not have any one particular metabolite that was statistically higher or 
lower than in all other species, however the metabolic profile was able to isolate the species on a 
separate cluster (fig. 7).  Overall, these applications demonstrate that we have successfully 
developed an LC-MS protocol that can screen for hundreds of polar molecules in biological 
samples. 
2.3.10 Conclusion 
We have developed a robust and versatile IP-LC-MS method for the simultaneous detection of 
hundreds of small polar molecules that are virtually impossible to analyze with classical reversed 
phase chromatography.  With regular cleaning this method avoids the contamination usually 
associated with typical IPRs while benefiting from the chromatographic resolution that that these 
compounds allow.  We have successfully applied the protocol to quantify the metabolic effect of 
a Sod-null genotype in D. melanogaster, chemically induced oxidative stress in D. melanogaster, 
and determine the metabolic profiles of four different Drosophila species.  By applying this 
protocol to three distinct biological questions, we demonstrate that this LC-MS method can be 
used to detect and quantify a diverse suite of molecules that are likely to be biologically relevant 
in a variety of systems.  Identification of currently unknown features using tandem mass 
spectrometry and applying this protocol to different systems, species, and even organisms is 
currently in progress.  Positive mode analysis with alkyl ammonium salts results in a constant 
background signal of the IPR, which can contribute to higher levels of ion suppression and 
system contamination.  Complementary protocols for positive mode analysis are currently being 
developed. 
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Figure 6: Heat map of metabolite profiles for the top 30 significantly different metabolites 
for Paraquat treated T5 lines vs. T5 control lines.  The level of each compound (x-axis) in 
each sample (y-axis) is represented as the fold change above the mean level of that compound.  
Along either axis, the compounds and samples are arranged by unsupervised hierarchical 
clustering. 
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Figure 7: Heat map of metabolite profiles for the top 30 significantly different metabolites 
for four Drosophila species.  The level of each compound (x-axis) in each sample (y-axis) si 
represented as the fold change above the mean level of that compound.  Along either axis, the 
compounds and samples are arranged by unsupervised hierarchical clustering. 
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Figure 8: A comparison of metabolite levels between (A) Sod-nulls vs. T5 controls, (B) 
Paraquat treated T5s vs. control T5s, (C) Four Drosophila species. “*” denotes significant 
difference of a sample (P<0.001) compared to all other samples unless otherwise clarified with 
lines.  Error bars represent standard deviation. 
A 
B 
C 
 39 
Chapter 3 
3 LC-MS metabolomic analysis of a Sod-null mutant and paraquat 
induced stress in Drosophila melanogaster 
Oxidative stress results in substantial biochemical and physiological perturbations in Drosophila 
melanogaster.  To generate oxidative stress, we have used both a Superoxide dismutase null-
allele and exposure to the chemical paraquat.  In this study we used liquid chromatography - 
mass spectrometry to quantify a large suite of metabolites and discovered wide spread changes to 
the metabolome in response to both stresses compared to control flies.  Glucose metabolism, 
pantothenate and coenzyme A biosynthesis, purine metabolism, and glutathione levels were all 
altered as a result of both experimental conditions.  We also discovered that, although either 
source results in oxidative stress, many metabolite levels differ between the two sources.  In fact, 
many features are significantly different between stress and control, but in opposite directions in 
the two different stressors.  The results from this study present a more complete survey of the 
metabolomic effects of oxidative stress in D. melanogaster than previous research and a more 
complete understanding of the metabolic consequences of this stress in general. 
3.1 Introduction 
In all organisms, oxidative stress (OS) results in a suite of detrimental physiological effects, 
many of which have been explored through the use of the Drosophila model system.  D. 
melanogaster have been used in studies of OS because of their ease of culturing and plethora of 
available genetic tools.  Surprisingly, even with extensive study, there is still little known about 
the effects of OS on global metabolite levels in this organism.  Description of a global response 
will allow us to better understand the metabolic processes affected by oxidative stress and 
possibly find novel biomarkers for OS.  To address this void in our knowledge, we set out to 
describe the global metabolic profiles of OS in D. melanogaster using liquid chromatography 
coupled to mass spectrometry (LC-MS) using two known sources of oxidative stress, one 
genetic, a Superoxide dismutase null allele, and one chemical, paraquat induced stress. 
The enzyme Superoxide dismutase (SOD) is part of the biological anti-oxidant defense 
mechanism, responsible for the dismutation of superoxide to hydrogen peroxide (Riley, 1994).  
Impairments in SOD function have been implicated in several diseases including Familial 
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amyotrophic lateral sclerosis (FALS), Parkinson’s disease, Alzheimer’s disease, dengue fever, 
cancer, Down’s syndrome, and cataracts (Noor et al., 2002).  The SOD family of enzymes is 
evolutionarily ancient, likely evolving soon after organisms developed the ability to survive in 
oxygen, and SOD homologs are found in essentially all groups of organisms from microbes to 
humans (Zelko et al., 2002).  In D. melanogaster, three isoforms of SOD are currently annotated: 
cytosolic SOD (SOD1), mitochondrial SOD (SOD2), and an extracellular SOD (SOD3).  This 
investigation focuses the effects of knocking out the Sod1 gene.  In D. melanogaster, the loss of 
SOD1 function results in drastic physiological changes with wide ranging effects, including a 
reduced lifespan, infertility, neurodegeneration, sensitivity to other oxidative sources, and an 
increase in spontaneous DNA damage (Bernard et al., 2011; Parkes et al., 1998b; Woodruff et 
al., 2004).  The adverse effects of the Sod-null mutation are believed to stem from oxidative 
damage associated with an accumulation of free radicals, generated via the Fenton reaction and 
the Haber-Weiss reaction.  This process begins with the reduction of iron by superoxide in the 
Haber-Weiss reaction.  Following the reduction of iron, the Fenton reaction can take place, in 
which iron reacts with hydrogen peroxide to generate hydroxyl radical, which is likely the cause 
of most oxidative damage (Buonocore, et al., 2010). 
Paraquat (PQ), a superoxide generating chemical that has historically been used as a herbicide, is 
commonly used in D. melanogaster as an experimental source of OS (Hosamani and 
Muralidhara, 2013; Phillips et al., 1989; Rzezniczak et al., 2011).  In vivo, PQ is reduced to a 
radical species in an NADPH-dependent matter.  The PQ radical spontaneously reacts with 
molecular oxygen to generate the superoxide radical and regenerate the non-radical form of PQ.  
Like a Sod-null mutation, paraquat treatment confers widespread, detrimental, physiological 
changes to D. melanogaster (Phillips et al., 1989; Rzezniczak and Merritt, 2012).  Though both a 
Sod-null mutation and paraquat treatment result in elevated levels of OS, little is known about 
specific similarities or differences between the stresses.  Assessing the particular changes to 
metabolite levels in each case may thus shed light on the mechanisms by which these stressors 
induce OS, as well as how OS is manifested within the larger metabolomic network. 
Physiological changes resulting from oxidative stress are a function of the accumulation of 
oxidative damage, driven by reactive oxygen species (ROS).  ROS can oxidize almost every type 
of cellular component including fatty acids, proteins, small molecule metabolites, and DNA.  
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Oxidative damage can lead to changes in gene expression, cell signaling and many other cellular 
processes (Girardot et al., 2004; Zou et al., 2000).  Gene expression and enzymatic activities are 
upstream processes that lead to changes in levels of metabolites.  The study of the entire set of 
metabolites and their levels in a system is known as metabolomics (Trethewey et al., 1999).  
Much like other wide-ranging biological analyses, e.g. genomics or transcriptomics, broad 
scoped, or untargeted, metabolomics offers insights into many biological processes and 
physiological states simultaneously.  Untargeted metabolomic approaches can also reveal 
unexpected changes to metabolic networks that were not, or could not be, predicted and would 
otherwise have been missed by smaller-scale, targeted, assays.  Liquid chromatography coupled 
to mass spectrometry (LC-MS) based metabolomic analyses are growing in popularity for broad-
based studies (Bogdanov et al., 2008; Kamleh et al., 2008; Sreekumar et al., 2009; Want et al., 
2013).  Since oxidative stress results in wide-scale changes in several biological processes, we 
suspect that alterations to metabolite levels will be present in flies under OS.  In fact, a broad 
array of changes to metabolite levels are observed under conditions associated with OS in 
different species (Bogdanov et al., 2008; Ho et al., 2013; Serkova et al., 2006; Sreekumar et al., 
2009). 
In this study, we use LC-MS based metabolomics to quantify the consequence of OS in D. 
melanogaster driven by two distinct sources of OS, a Sod-null mutation and PQ.  We determine 
the unique metabolic profiles of both forms of oxidative stress to assess the similarities and 
differences between them with an ultimate goal of identifying common markers of OS.  In both 
cases, we found large-scale metabolic differences between OS conditions and control lines.  
Overall, we find that OS leads to broad changes in the metabolome: 28% of metabolites are 
affected in Sod-null flies, 13% in paraquat treated flies.  We find both similarities in the stress 
response (23 known metabolites altered in the same direction under both stressors), and striking 
differences (17 features of known structure that were significant in opposite directions).  
3.2 Materials and methods 
3.2.1 Fly stocks and treatment 
The cSod1-null genotype and the transgenic Sod rescue control have been described previously 
(Campbell et al., 1986; Parkes et al., 1998b; Phillips et al., 1989), but will be briefly described 
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here.  The Sod1-null allele, cSodn108, hereafter simply the Sod-null, was generated via 
ethylmethylsulfonate mutagenesis (Campbell et al., 1986), and introduced into Oregon R 
recipient strain to generate w+; T0/T0; cSODn108red/TM3 (Parkes et al., 1998).  The Sod 
transgenic rescue control line w+; T5/T5; cSODn108red/TM3, here referred to as T5 controls, was 
generated by introducing a Sod transgene under control of the native Sod1 promoter into the 
same background. 
The data used in this analysis is the same raw data used by Knee et al. (2013) (Chapter 2), which 
focused on method development.  This study expands on the scope of previous results by 
inclusion of metabolite identities revealed by tandem mass spectrometry and subsequent 
confirmation by purchased standards.  The current study also uses all the currently identified 
metabolites and their concentrations to identify biochemical pathways affected by the two 
sources of OS.  Both the previous study (Knee et al., 2013; Chapter 2) and the current use a very 
lenient missing value cut-off.  For further publication purposes, we are investigating more 
conservative analysis schemes, i.e. including only features that are present in at least some 
minimum percentage (e.g. 50 or 80%) of a sample type.  Such cut-off values have been 
demonstrated more consistently result in biologically meaningful results (Hrydziuszko and 
Viant, 2012; Smith et al., 2006). 
For the Sod-null vs. control experiment, groups of five males and five females were placed in 
over 20 vials containing standard cornmeal-yeast-agar-corn syrup medium and allowed to lay 
eggs for four days.  All flies, in this and all other experiments and treatments were maintained at 
250 C with a 12 hour light:dark cycle.  Adult male progeny from several vials, aged 2-4 days, 
were anesthetized by CO2, pooled, and collected into vials with 15 individuals before being flash 
frozen with liquid nitrogen and kept at -80 oC until the day of extraction.  This analysis used 56 
biological replicates for each sample type. 
In the PQ induced stress experiment three SOD+ lines, the T5 ‘rescue’ control line, 
w;6326;6326, a sub-line of the isogenic 6326 (Hoskins et al., 2001), and w;VT83;VT83 inbred 
lines isolated in Vermont, USA, were either exposed to paraquat or kept under benign 
conditions.  Three lines were chosen to assess natural variability in response to PQ treatment.  
For each line, over 20 vials were set-up to contain five males and five females which were 
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allowed to lay eggs in either standard medium or medium treated with a final concentration of 
0.5 mM paraquat.  Newly emerging flies were transferred to fresh vials of paraquat treated, or 
standard, CYA medium and aged for two more days before being flash frozen and stored.  To 
develop this protocol for inducing chronic OS across multiple life stages, we screened nutrient 
medium supplemented with a series of paraquat concentrations.  At concentrations of 1mM or 
higher, the T5 control lines did not produce viable flies (data not shown).  This analysis used 20 
biological replicates of each sample type. 
Our metabolite extraction protocol has been described previously (Knee et al., 2013).  Briefly, 
groups of 15 adult male flies were weighed to the nearest 0.01mg with a microbalance (MX5 
Balance, Mettler Toledo AG, Greifensee Switzerland) and extraction buffer was added in a 
concentration of 6.35 µL/mg.  The extraction solvent used in this study was 3:1:1 mixture of ice-
cold methanol:chloroform:water (adapted from Kamleh et al., 2008).  The flies were 
homogenized with a bead beater (TissueLyser, Qiagen) and centrifuged, at 40C and 13000 x g, 
and the supernatant recovered to remove protein and debris.  Extracts were kept at -800C until 
LC-MS analysis was run.  Before injection into the LC-MS, fly extracts were thawed and diluted 
with solvent A (below) to reduce the combined methanol:chloroform content to approximately 
20%. 
3.2.2 LC-MS parameters 
LC-MS analysis was performed on an Ultimate3000RS (Dionex, ThermoScientific) (U)HPLC 
system coupled to a MicroTOF QII (Bruker Daltonic, Billerica, MA) mass spectrometer with an 
electrospray ionization (ESI) source as previously described (Knee et al., 2013; Chapter 2).  
Separation was achieved at 0.4 ml/min on a 1.7 µm, 2.1x100 mm Kinetex C18 column 
(Phenomenex, Torrance, CA) maintained at 500 C.  Solvent A consisted of 10 mM diamyl 
ammonium acetate (DAA) at pH 4.95. Solvent B was 100% methanol.  The gradient used for 
these analyses is represented on Table 1. 
The mass spectrometer was run with the following ESI parameters: capillary: 4 kV; nebulizer 
pressure: 4 bar; dry gas flow: 9Lmin−1; dry gas temperature: 2000 C.  At the beginning of each 
chromatographic run, sodium formate (0.5 mg/mL in an equivalent mixture of water and 
isopropanol) was injected into the mass spectrometer, in a separate segment for automatic 
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calibration.  Quality control (QC) and blank injections were used periodically (approximately 
every 10 samples) throughout each analysis. 
3.2.3 Data handling and statistical tests 
Raw MS data was acquired using Hystar 3.2 software and evaluated using DataAnalysis 4.0 
(Bruker Daltonics, Billerica MA).  FindMolecularFeatures (FMF; Bruker Daltonics, Billerica 
MA) automatic peak finding software was used in conjunction with DataAnalysis 4.0 to generate 
a retention time: mass to charge ratio (m/z) pair termed a bucket.  FMF compounds in the 
analysis window were imported into ProfileAnalysis 2.0 software (Bruker Daltonics, Billerica 
MA).  The analysis window included the area after the calibration segment starting at 0.4 
minutes and ending before the high organic wash stage at 24 minutes.  ProfileAnalysis 2.0 was 
used for principle component analysis (PCA) and t-test analysis.  Bucket features were 
normalized by the sum of all buckets in the analysis for t-test, and further Pareto scaling was 
used for PCA.   
Features of known structure were validated using commercial standards and buckets generated 
from PCA were exported into comma separated value format and uploaded to MetaboAnalyst 
software (http://www.metaboanalyst.ca/; Xia et al., 2009, 2012).  Pathway analysis was run on 
the MetaboAnalyst server, which uses Goemanós Globaltest (Goeman and Bühlmann, 2007) for 
pathway enrichment analysis, and a relative-betweeness centrality measure for pathway topology 
analysis.  Pathway enrichment is a type of quantitative enrichment analysis similar to analyses 
used for gene expression datasets.  Pathway enrichment combines over-representation analysis, 
in which metabolite sets are given a significance based on their representation on (i.e. 
presence/absence in) a particular pathway, and concentrations of the metabolites within these 
pathways (Xia et al., 2009, 2012).  The results of pathway enrichment analysis are represented 
on the y-axis of the metabolome view of a pathway analysis.  Pathway topology analysis takes 
into account pathway structure to determine which pathways are most likely affected by 
conditions under study (Xia et al., 2009, 2012).  The results of topology analysis are represented 
on the x-axis and expressed as an impact.  The impact is based on connectivity of metabolites in 
a particular pathway and normalized by the impact of the individual metabolites in that pathway.  
MetaboAnalyst uses the Kyoto Encylopedia of Genes and Genomes (KEGG) database for its 
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back end knowledge and uses the Drosophila melanogaster reference genome for the analysis 
(Xia et al., 2009, 2012).  The global metabolic profile was reconstructed in Fig. 11 also using the 
KEGG database. 
3.3 Results 
3.3.1 Metabolomic analysis of a Sod-null mutation 
We used an LC-MS protocol for the comprehensive screening of small molecule metabolites in 
D. melanogaster to determine the effects of a Sod-null mutation.  Chromatography was 
performed with an ion-pairing reagent and a C-18 column and MS analysis was performed in 
negative mode.  Previous studies of a variety of complex phenotypes, have shown that Sod-null 
flies are under chronic OS, presumably caused by the inability to remove superoxide anion 
(Bernard et al., 2011; Campbell et al., 1986; Parkes et al., 1998b).  Here, we quantify the effects 
of a Sod-null mutation on the metabolomic profile of D. melanogaster, effects that likely 
contribute to many, if not all, of the larger-scale phenotypes previously established for this 
genotype.  We found that the loss of SOD activity leads to significant and substantial, broad 
reaching effects across the metabolome.  A total of 168 out of 594 shared features (potential 
metabolites), 28 %, were detected at significantly different concentrations in the Sod-null and 
control flies (Table 4).  Out of the 594 shared features, 53 were confirmed metabolites, and 38 of 
these known metabolites were significantly different between Sod-nulls and controls.  The broad 
differences in metabolite levels between the sample types allowed for the clear separation of the 
Sod-null and control flies along Principal component 1 (PC1) in principal component analysis 
(PCA; Fig. 9a).  Sod-null mutants were also distinguishable from control flies using hierarchical 
clustering in heat map analysis (Fig. 10a). 
3.3.2 Metabolomic analysis of paraquat-induced stress 
We used the same UHPLC-MS protocol for the comprehensive screening of small molecule 
metabolites in flies exposed to the superoxide generating chemical, PQ, as we did for the Sod-
null flies.  PQ is commonly used to experimentally generate OS and its exposure to D. 
melanogaster causes broad reaching physiological and biochemical changes (Hosamani and 
Muralidhara, 2013; Rzezniczak et al., 2011).  Flies from the T5 Sod control line were reared 
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under constant exposure to low levels of paraquat and compared to T5 flies reared on standard 
lab media.  Chronic PQ exposure across the life stages of D. melanogaster resulted in a large 
metabolic response.  A total of 59 out of 459 shared features (potential metabolites), 13 %, were 
detected at significantly different concentrations between PQ treated and control flies (Table 4).  
Out of the 459 shared features, 41 were confirmed metabolites, and 17 of these known 
metabolites were significantly different in paraquat treated and control flies.  The wide, 
metabolic differences detected in paraquat treated flies, is reflected in separation of the two 
sample types along PC1 in the PCA (Fig. 9B).  
3.3.3 Metabolic comparison between stresses 
Comparison of the similarities and differences between genetically and chemically driven OS 
allows us to draw conclusions about OS in general.  Both sources of OS resulted in substantial 
changes to the D. melanogaster metabolome, however the Sod-null allele had a significantly 
wider effect (Table 4; Fisher Exact Test P<0.0001).  The number of detected metabolites of 
known structure was higher in the Sod-null analysis compared to the paraquat analysis, 55 and 
45, respectively.  The difference in detected metabolites of known structure may be attributed to 
PQ stress drastically reducing the concentrations of these metabolites below our limits of 
detection.  The Sod-null allele and paraquat treatment are both used for models of oxidative 
stress, however the significantly altered features in both stresses differed both qualitatively and 
quantitatively suggesting that these two stress conditions are actually significantly different at the 
metabolomic level.  Only approximately half (23 out of 45) of significantly different features in 
paraquat-induced stress were significantly altered in the same direction as the Sod-null genotype. 
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Figure 9: PCA scores and loading plots of the metabolic profiles representing A) the Sod-
null vs. T5 control lines and B) T5 control lines under paraquat stress and control 
parameters. 
B) 
A) 
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Figure 10: Heat maps of the metabolic profiles, consisting of the top 59 significantly 
different features, of A) Sod-nulls vs. T5 controls and B) PQ treated flies vs. controls.  The 
level of each compound (x-axis) in each sample (y-axis) represented as the fold change above the 
mean level of that compound.  Along either axis, the compounds and samples are arranged by 
unsupervised hierarchical clustering.  
3.3.4 Metabolic pathways affected by a genetic and chemically induced oxidative 
stress 
The Sod-null mutation and paraquat induced stress resulted in a suite of differences across the fly 
metabolome.  Some individual metabolites may be interesting in themselves, but our larger 
interest is in the pathways and networks affected by these stresses.  Pathway analysis, combining 
enrichment analysis and topology analysis, was used identify pathways affected by both stresses 
(Wu et al., 2012; Xia et al., 2009) and results are summarized in Fig. 11.  Tables 5 and 6 list the 
metabolic pathways, extracted from the KEGG database, that affected by the Sod-null mutation 
and paraquat induced stress, respectively.  An overall, simplified, metabolome view of 
metabolites detected and altered in levels is represented in Fig. 12.  A colour gradient represents 
the metabolite levels in stressed samples compared to controls (Fig. 11).  Figures 11 and 12 
highlight the conclusions that both the Sod-null allele and paraquat treatment result in substantial 
changes to the metabolome, and that each source of oxidative stress results in distinct responses 
to metabolite and affected pathways. 
 49 
Table 4: Summary of metabolomic comparisons 
Stress Total Features 
Significantly 
different 
features 
Features of 
known 
structure 
Significantly 
different known 
compounds 
Significant 
shared 
responses 
Significant 
opposite 
responses 
Sod-null 594 168 (28%) 55 36 
23 17 Paraquat 459 59 (13%) 45 17 
 
3.3.5 Glutathione metabolism and related pathways 
Glutathione metabolism was similarly affected by genetic and chemically induced stress (Fig. 
12; pathway 19).  The relative concentration of oxidized glutathione (GSSG) was higher in both 
sources of oxidative stress compared to controls (Sod-nulls: P<1x105; PQ: P(0.02696)).  The 
reduced form of glutathione (GSH) was not affected by the Sod-null genotype (P(0.95)), 
however there was a significant 1.31 fold increase in PQ treated flies (P<1x105). Glutamate, a 
precursor to glutathione synthesis, was not altered in response to either stress.  Cysteine, another 
precursor to glutathione, was not altered in response to the Sod-null stress, but was undetectable 
in PQ induced stress experiment.  The mass of glycine, a precursor to glutathione, falls below the 
detectable scope of this study.  
3.3.6 Glutamine and purine metabolism 
The amino acid glutamate is involved in several pathways including conversion into glutamine 
(Fig. 12; pathway 5 & 23).  The relative concentration of glutamine is increased in both 
genetically (1.42 fold: P<1x105) and chemically (1.90 fold: P<1x105) generated OS.  Glutamine 
is also involved in purine metabolism (pathway 18), a pathway largely affected by the Sod-null 
mutation, but not paraquat treatment.  Adenosine monophosphate (AMP) (P<1x105), adenosine 
triphosphate (ATP) (P(0.01047)), and urate (P(0.00724)), metabolites in the purine metabolism 
pathway, were reduced in Sod-nulls compared to controls. 
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3.3.7 Pantothenate and CoA biosynthesis 
Pantothenate concentration was consistently lower in Sod-nulls (2.1 fold: P<1x105) and in PQ 
treated flies (1.83 fold: P<1x105), than in controls, suggesting this compound may be an 
appropriate general biomarker for oxidative stress in flies.  Coenzyme A (CoA) was also reduced 
in Sod-nulls by a factor of 1.2 (P(0.00855)), while it remained undetected in paraquat treated 
flies.  One downstream metabolite product of the pantothenate and CoA biosynthesis pathway 
with several functions is acetyl-CoA, which was reduced in Sod-nulls (1.37 fold: P(0.0136)), and 
undetected in the PQ comparison. 
 
Figure 11: Predicted impact and significance of metabolic pathways in A) Sod-null and B) 
Paraquat treated flies 
3.3.8 Changes to amino acid concentrations 
The two sources of OS both affected the concentrations of amino acids in in D. melanogaster 
(Appendices E and F).  Chemically and genetically driven OS impacted amino acid metabolism, 
however the effects that each stress had on amino acid metabolism were different (Tables 5 and 
6).  Sod-null flies had significantly higher concentrations of arginine (P(0.00001)), methionine 
(P<1x105), ornithine (0.00289), threonine (P<1x105) and valine (P(0.00074)), compared to 
control flies.  PQ treated flies had higher concentrations of lysine (P(00063)) and tyrosine 
(P(0.00074)) compared to controls, while phenylalanine (P(0.01427)) was detected at lower 
concentrations.  In both sources of OS, asparagine (Sod-nulls: P(0.00026; PQ: P(0.00483))  and 
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glutamine (Sod-nulls: P<1x105; PQ: P<1x105) concentrations were elevated, while histidine 
(Sod-nulls: P(0.00001); PQ: P(0.00179)) and proline (Sod-nulls: P(0.01899); PQ: P(0.00318)) 
concentrations were reduced.  The concentration of (iso)leucine (P(0.0028)) was elevated in Sod-
nulls, in contrast to PQ treated flies where (iso)leucine concentration was reduced (P(0.00048)). 
 
Table 5: Pathway analysis of Sod-null genotype 
 Pathway 
Total 
Compounds Hits Raw p -log(P) 
Holm 
adjust FDR Impact 
1 Pantothenate and CoA biosynthesis 12 1 6.78E-34 76.374 3.05E-32 3.05E-32 0 
2 Arginine and proline metabolism 37 5 3.20E-23 51.796 1.41E-21 7.20E-22 0.46944 
3 Nitrogen metabolism 7 2 1.24E-22 50.439 5.35E-21 1.87E-21 0 
4 Pyrimidine metabolism 41 3 2.28E-21 47.53 9.58E-20 2.57E-20 0.13888 
5 
D-Glutamine and D-
glutamate 
metabolism 
5 3 5.17E-21 46.711 2.12E-19 4.65E-20 1 
6 
Alanine, aspartate 
and glutamate 
metabolism 
23 6 1.05E-20 46 4.21E-19 7.90E-20 0.52703 
7 Aminoacyl-tRNA biosynthesis 67 12 2.01E-14 31.538 7.84E-13 1.29E-13 0.13793 
8 Pentose phosphate pathway 19 1 1.89E-13 29.297 7.18E-12 1.06E-12 0.05931 
9 
Amino sugar and 
nucleotide sugar 
metabolism 
34 2 1.25E-10 22.802 4.63E-09 6.25E-10 0.13889 
10 
Valine, leucine and 
isoleucine 
biosynthesis 
13 1 2.67E-10 22.045 9.60E-09 1.10E-09 0 
11 
Glycine, serine and 
threonine 
metabolism 
25 2 2.69E-10 22.035 9.60E-09 1.10E-09 0.2825 
12 
Cysteine and 
methionine 
metabolism 
25 2 4.82E-09 19.15 1.64E-07 1.81E-08 0.09236 
13 Starch and sucrose metabolism 17 2 1.11E-07 16.009 3.68E-06 3.86E-07 0.07338 
14 Glycerolipid metabolism 16 1 9.26E-07 13.893 2.96E-05 2.98E-06 0.04096 
15 Tyrosine metabolism 30 2 1.01E-06 13.809 3.12E-05 3.02E-06 0.24096 
16 Glycerophospholipid 27 2 2.28E-06 12.993 6.83E-05 6.40E-06 0.09682 
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 Pathway 
Total 
Compounds Hits Raw p -log(P) 
Holm 
adjust FDR Impact 
metabolism 
17 Histidine metabolism 7 2 3.34E-06 12.61 9.68E-05 8.83E-06 1 
18 Purine metabolism 64 6 0.00053587 7.5316 0.015004 
0.001339
7 0.11528 
19 Glutathione metabolism 26 6 0.0055828 5.1881 0.15074 0.013222 0.4794 
20 
Phenylalanine, 
tyrosine and 
tryptophan 
biosynthesis 
4 2 0.021147 3.8562 0.54983 0.045316 1 
21 Phenylalanine metabolism 10 2 0.021147 3.8562 0.54983 0.045316 0.69231 
22 Riboflavin metabolism 7 1 0.050198 2.9918 1 0.10268 0 
23 Citrate cycle (TCA cycle) 20 4 0.066843 2.7054 1 0.12927 0.15712 
24 
Nicotinate and 
nicotinamide 
metabolism 
9 2 0.068946 2.6744 1 0.12927 0.29231 
25 Fatty acid metabolism 38 2 0.11241 2.1856 1 0.19276 0.25512 
26 Butanoate metabolism 21 4 0.1211 2.1111 1 0.19276 0 
27 Lysine degradation 17 2 0.14734 1.915 1 0.19276 0 
28 Fatty acid elongation in mitochondria 27 1 0.15161 1.8864  1 0.19276 0.2522 
29 Glycolysis or Gluconeogenesis 25 1 0.15161 1.8864 1 0.19276 0.04208 
30 
Valine, leucine and 
isoleucine 
degradation 
35 1 0.15161 1.8864 1 0.19276 0.0357 
31 Fatty acid biosynthesis 38 1 0.15161 1.8864 1 0.19276 0.02717 
32 
Synthesis and 
degradation of 
ketone bodies 
5 1 0.15161 1.8864 1 0.19276 0 
33 Tryptophan metabolism 23 1 0.15161 1.8864 1 0.19276 0 
34 Inositol phosphate metabolism 24 1 0.15161 1.8864 1 0.19276 0 
35 Terpenoid backbone biosynthesis 13 1 0.15161 1.8864 1 0.19276 0 
36 Fructose and mannose metabolism 18 1 0.15421 1.8695 1 0.19276 0.17705 
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 Pathway 
Total 
Compounds Hits Raw p -log(P) 
Holm 
adjust FDR Impact 
37 Sphingolipid metabolism 18 2 0.16179 1.8215 1 0.19677 0.03571 
38 Pyruvate metabolism 24 2 0.17452 1.7457 1 0.20137 0.19182 
39 
Glyoxylate and 
dicarboxylate 
metabolism 
16 2 0.17452 1.7457 1 0.20137 0 
40 Biotin metabolism 5 1 0.20033 1.6078 1 0.22537 0 
41 Propanoate metabolism 18 2 0.52684 0.64086 1 0.57247 0.03333 
42 Methane metabolism 9 1 0.54702 0.60326 1 0.57247 0.4 
43 Cyanoamino acid metabolism 6 1 0.54702 0.60326 1 0.57247 0 
44 
Porphyrin and 
chlorophyll 
metabolism 
23 1 0.56942 0.56314 1 0.58236 0 
45 
Ubiquinone and 
other terpenoid-
quinone biosynthesis 
3 1 0.68549 0.37762 1 0.68549 0 
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Table 6: Pathway analysis of paraquat induced stress. 
 Pathway 
Total 
Compounds Hits Raw p -log(P) 
Holm 
adjust FDR Impact 
8 Pentose phosphate pathway 19 2 7.05E-20 44.099 2.54E-18 2.54E-18 0.23048 
4 Pyrimidine metabolism 41 1 7.31E-12 25.641 2.56E-10 1.32E-10 0 
7 Aminoacyl-tRNA biosynthesis 67 10 1.38E-11 25.004 4.70E-10 1.42E-10 0 
2 Arginine and proline metabolism 37 5 1.58E-11 24.872 5.21E-10 1.42E-10 0.46944 
5 D-Glutamine and D-glutamate metabolism 5 2 5.86E-11 23.56 1.88E-09 3.52E-10 1 
3 Nitrogen metabolism 7 2 5.86E-11 23.56 1.88E-09 3.52E-10 0 
6 Alanine, aspartate and glutamate metabolism 23 5 8.04E-11 23.244 2.41E-09 4.14E-10 0.45946 
1 Pantothenate and CoA biosynthesis 12 1 1.14E-08 18.287 3.31E-07 5.14E-08 0 
19 Glutathione metabolism 26 5 3.01E-08 17.319 8.43E-07 1.20E-07 0.4794 
13 Starch and sucrose metabolism 17 2 1.39E-07 15.791 3.74E-06 4.99E-07 0.07338 
27 Lysine degradation 17 1 4.38E-05 10.035 0.0011392 0.00013145 0 
40 Biotin metabolism 5 1 4.38E-05 10.035 0.0011392 0.00013145 0 
17 Histidine metabolism 7 2 0.0018535 6.2907 0.044484 0.0051328 1 
20 
Phenylalanine, tyrosine 
and tryptophan 
biosynthesis 
4 2 0.0078395 4.8486 0.18031 0.018815 1 
21 Phenylalanine metabolism 10 2 
0.007839
5 4.8486 0.18031 0.018815 0.69231 
45 
Ubiquinone and other 
terpenoid-quinone 
biosynthesis 
3 1 0.0089931 4.7113 0.18886 0.020235 0 
15 Tyrosine metabolism 30 2 0.016711 4.0917 0.33422 0.035388 0.24096 
37 Sphingolipid metabolism 18 1 0.068977 2.674 1 0.13795 0.03571 
25 Fatty acid metabolism 38 1 0.14081 1.9603 1 0.2668 0.09789 
18 Purine metabolism 64 5 0.1797 1.7165 1 0.32346 0.10119 
11 Glycine, serine and threonine metabolism 25 1 0.28987 1.2383 1 0.47433 0.04054 
10 Valine, leucine and isoleucine biosynthesis 13 1 0.28987 1.2383 1 0.47433 0 
16 Glycerophospholipid metabolism 27 2 0.38268 0.96054 1 0.57515 0.09682 
41 Propanoate metabolism 18 1 0.39389 0.93169 1 0.57515 0 
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 Pathway 
Total 
Compounds Hits Raw p -log(P) 
Holm 
adjust FDR Impact 
9 
Amino sugar and 
nucleotide sugar 
metabolism 
34 2 0.41309 0.88409 1 0.57515 0.13889 
36 Fructose and mannose metabolism 18 2 0.41538 0.87855 1 0.57515 0.2 
14 Glycerolipid metabolism 16 1 0.44915 0.8004 1 0.59886 0.04096 
24 
Nicotinate and 
nicotinamide 
metabolism 
9 1 0.55702 0.58516 1 0.64815 0.29231 
44 Porphyrin and chlorophyll metabolism 23 1 0.56131 0.57748 1 0.64815 0 
23 Citrate cycle (TCA cycle) 20 2 0.56661 0.56809 1 0.64815 0.07086 
26 Butanoate metabolism 21 2 0.60712 0.49903 1 0.64815 0 
22 Riboflavin metabolism 7 1 0.60832 0.49706 1 0.64815 0 
29 Glycolysis or Gluconeogenesis 25 1 0.61214 0.4908 1 0.64815 0.0855 
34 Inositol phosphate metabolism 24 1 0.61214 0.4908 1 0.64815 0 
38 Pyruvate metabolism 24 1 0.65503 0.42307 1 0.65503 0 
39 
Glyoxylate and 
dicarboxylate 
metabolism 
16 1 0.65503 0.42307 1 0.65503 0 
 
 56 
 
Figure 12: Simplified metabolic architecture of Sod-null and paraquat induced stress.  
Colour-coded box to the left of the metabolite corresponds to the Sod-null vs. control comparison 
and the box on the right corresponds to the paraquat treated vs. control comparison.  Metabolites 
surrounded by a box indicate the metabolite is an isomeric compound that cannot be 
distinguished from other isomer forms.  Metabolites without a colour-coded box on one side, or 
both, were not detected in the respective analyses. Lines with arrows indicate direction and 
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single enzyme conversion between two metabolites.  Lines without arrows indicate multi-step 
conversion to connected metabolites. 
3.4 Discussion 
3.4.1 Oxidative stress leads to changes in the metabolic profile of Drosophila 
melanogaster 
OS is a degenerative condition and in humans is associated with several diseases and pathologies 
including cardiovascular disease (Dhalla et al., 2000), Parkinson’s disease (Jenner, 2003), and 
FALS (Barber and Shaw, 2010).  Here, we use the D. melanogaster model system to 
demonstrate substantial changes in the metabolic profile in response to OS arising from two 
sources of OS: a Sod-null genotype and a chemical oxidant.  Considering the breadth and 
magnitude of physiological and biochemical changes that both these stresses confer (Bernard et 
al., 2011; Hosamani and Muralidhara, 2013; Parkes et al., 1998b; Phillips et al., 1989), metabolic 
changes were expected, however, changes in the measured metabolome of up to 28% were 
surprising. 
Sod knock-out/null alleles and paraquat have been used as models of oxidative stress and disease 
states in a variety of organisms (Van Raamsdonk and Hekimi, 2009; Sentman et al., 2006; Wei et 
al., 2001).  Relatively little is known about global metabolomic response to OS in D. 
melanogaster, although we do have a better understanding of the metabolomic effects in other 
model species, including human cells and mice (Ho et al., 2013; Jozefczuk et al., 2010; Weeks et 
al., 2006).  The suite of metabolites that are significantly altered by either source of OS in our 
models are interesting both in the unique features and in the features that are shared with other 
sources of oxidative stress. 
3.4.2 Glutathione metabolism 
The Sod-null mutation and PQ exposure lead to changes to glutathione metabolism (Fig. 11, 
pathway 19).  Glutathione is a major anti-oxidant source in most cells; its reduced form (GSH) 
reacts with ROS, and substrates oxidized by ROS, to generate the oxidized form (GSSG) (Owen 
and Butterfield, 2010).  The GSH/GSSG ratio is considered an indicator of cellular health and 
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decreases in the GSH/GSSG ratio have been observed in other studies of OS and OS related 
diseases (Bogdanov et al., 2008; Ho et al., 2013; Serkova et al., 2006; Tissot van Patot et al., 
2009).  Decreases in GSH levels as a result of OS, have been demonstrated to increase levels of 
pyroglutamate (Pederzolli et al., 2007a), a metabolite involved in glutathione metabolism.  
Although we do not detect decreases in GSH in Sod-nulls, we did observe increased levels of 
pyroglutamate, suggesting increased production of this compound, possibly to increase 
availability for protection from OS.  The lack of change in GSH may reflect increased GSH 
synthesis, although two of the precursors, glutamate and cysteine, were not detected at different 
levels between conditions.  To maintain the available GSH needed to reduce ROS, GSSG may be 
cycled back to GSH using the reducing power of NADPH, which may partly explain the 
observed large decrease in NADPH. 
Glutathione metabolism was also affected by chronic PQ exposure, although to a different 
extent.  GSSG levels were also elevated in PQ exposed flies, reflecting the Sod-null model and 
underscoring the importance of GSSG as a marker of oxidative stress.  In PQ induced stress, 
glutamate, a precursor used in glutathione synthesis, was not different between samples.  In 
contrast to the Sod-null analysis, GSH was detected at higher concentrations.  The differences in 
the concentrations of GSH and GSSG between each stress may be attributed to the different 
standing concentrations of different ROS present in each stress. 
3.4.3 NADPH, the pentose phosphate pathway, and glucose metabolism 
NADPH, which functions in the reduction of GSSG back to GSH, is an important cofactor 
involved in many cellular processes and our observation of reduced concentrations in Sod-nulls 
is consistent with previous studies in the Merritt lab (Bernard et al., 2011).  Glucose 6-phosphate 
dehydrogenase (G6PDH), 6-Phopshogluconate dehydrogenase (6PGDH), NADP-Isocitrated 
dehydrogenase (IDH), and malic enzyeme (ME) are involved in central metabolism and the 
pentose phosphate pathway, and are largely responsible for the reduction of NADP to NADPH.  
G6PDH, IDH, and ME have lower activities in Sod-nulls under benign conditions (Bernard et al., 
2011).  These lower activities likely contribute to the lower NADPH concentration we observe.  
In addition, NADPH is likely being consumed in recycling GSSG.  Sedoheptulose 7-phosphate, 
an intermediate in the pentose phosphate pathway, was increased in both stresses.  The increase 
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of sedoheptulose 7-phopshate in both stresses highlights this molecule as a possible marker of 
OS and reinforces the notion that OS affects the pentose phosphate pathway.  Overall, the 
previous study of this Sod-null in the Merritt lab found a general reduction in many enzymes 
involved in central metabolism (Bernard et al., 2011).  The current metabolomics study finds 
alterations to central metabolism and the pentose phosphate pathway, consistent with this pattern 
of reduced metabolic activity in the Sod-null flies (Table 5; Pathways 8, 23, & 29).   
Sugar and sugar phosphates are important metabolites involved in central metabolism and the 
pentose phosphate pathway.  Despite alterations to pathways 8, 9, 13 and 29 (Fig. 11), the 
combined sum of all hexoses was not significantly affected by either of the two sources of 
oxidative stress.  A balance between synthesis and catabolism of gluconate and trehalose 6-
phosphate might explain the consistent concentration of hexoses.  Gluconate was elevated, and 
trehalose 6-phosphate was reduced in Sod-nulls, while the pattern was opposite in PQ treated 
flies.  Gluconate and trehalose 6-phosphate represent alternative pathways for glucose 
metabolism and their substantial changes in concentrations, in opposite directions, may balance 
the synthesis and catabolism of glucose.  Trehalose has been observed to have a functional role 
in protection against OS in C. albicans and the protection conferred was observed to be higher 
under direct OS from hydrogen peroxide as opposed to under oxidative tolerance (Alvarez-Peral 
et al., 2002).  The distinction between tolerance and acute exposure, may underscore the 
difference seen between our models.  While the Sod-null model has a reduced ability to remove 
endogenous superoxide and metabolize it to hydrogen peroxide, treatment with PQ generates 
exogenous superoxide, in the presence of normal levels of SOD enzyme.  It might therefore be 
expected that the principal imbalance in ROS in the two OS models would be fundamentally 
different; in the Sod-null model superoxide should be elevated and hydrogen peroxide reduced, 
while in the PQ model the functional SOD should largely remove excess superoxide and 
generate more hydrogen peroxide.   
Despite the well-known effects of oxidative stress on mitochondrial function and energy 
production (Cheng et al., 2013), we did not detect any variation in metabolite concentrations 
across the tricarboxylic acid (TCA) cycle in response to either stress.  Interestingly, (iso)citrate 
and oxoglutarate concentrations were not influenced by the Sod-null genotype although 
Isocitrate dehydrogenase, responsible for the conversion of isocitrate to oxoglutarate, was 
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previously described to be reduced in Sod-nulls (Bernard et al., 2011).  The lack of change in the 
concentrations of metabolites involved in the TCA cycle that we observe may result from 
metabolic rewiring geared towards the synthesis of other compounds.  The lower FAD 
concentration that we observe in Sod-nulls may result from such a rewiring as succinate 
dehydrogenase converts succinate into fumarate using FAD as a cofactor.  We did not, however, 
find a reduction in succinate or fumarate in Sod-nulls.  
3.4.4 Oxidative phosphorylation and purine metabolism 
Oxidative phosphorylation, which utilizes FAD(H2), is responsible for generating adenosine 
triphosphate (ATP) from adenosine diphosphate (ADP), both high energy molecules with many 
functions.  ATP, ADP, and adenosine monophosphate (AMP), are synthesized de novo in the 
purine metabolism pathway.  This pathway can be fed by, or generate, glutamine, and glutamine 
concentrations were higher in both models of OS.  Under various conditions, glutamine can act 
as a major energy source (Fox et al., 1996; Matés et al., 2002).  The low ATP concentrations in 
the Sod-null flies suggest that energy reserves are low in these flies and the higher glutamine 
concentrations could reflect shunting of metabolic resources to this alternative energy source in 
the Sod-nulls.  An alternate explanation for low ATP concentrations may be that under SOD-
depleted conditions cellular metabolism is diverted away from energy production, so as to reduce 
flux through the electron transport chain from which superoxide is inevitably released.  Whether 
glutamine is being funneled towards, or away from, purine metabolism is unclear, but glutamine 
may be being used to counteract reduced levels of metabolites in purine metabolism.  
Dysfunction in purine metabolism leads to activation of apoptotic pathways (Holland et al., 
2011), and glutamine also plays important roles in the regulation of apoptosis (reviewed in: 
Matés et al., 2006).  The interplay between purine metabolism and glutamine levels may be 
underlying the response of D. melanogaster to OS.  Purine metabolism also generates urate, one 
of the most important anti-oxidants in humans (Liu et al., 2011).  The decrease in urate in Sod-
nulls is likely a result of increases in urate oxidation products, and has previously been described 
to be decreased under OS conditions in humans (Bogdanov et al., 2008). 
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3.4.5 Evidence of OS associated neurodegeneration 
Both sources of OS resulted in changes in concentrations of metabolites in the pantothenate and 
coenzyme A (CoA) synthesis pathway (Fig. 11; pathway 1).  Pantothenate concentrations were 
lower in both sources of OS, suggesting that this metabolite may be a general biomarker of OS in 
flies.  The changes of metabolite concentrations in this pathway are consistent with previously 
reported changes in expression of genes involved in the pantothenate and CoA synthesis pathway 
(Zou et al., 2000).  Zou et al. (2000) observed a decrease in acetyl-CoA synthase mRNA 
required for the synthesis of the enzyme responsible for the production of acetyl-CoA from CoA. 
Both of these metabolites are reduced in Sod-nulls.  Acetyl-CoA synthase also produces AMP, a 
metabolite also decreased in Sod-null flies.  Dysfunction in the pantothenate and CoA synthesis 
pathway is implicated in OS associated neurodegeneration (Brunetti et al., 2012).  Our results 
indicating alterations in this pathway in the Sod-nulls are thus consistent with earlier work using 
Sod-null alleles as models of neurodegeneration (Elia et al., 1999; Mockett et al., 2003; Parkes et 
al., 1998b; Phillips et al., 1989; Watson et al., 2008).  In addition, previous work has associated 
loss of SOD activity and OS with the loss of dopaminergic neurons in D. melanogaster models 
of Parkinson’s disease (Botella et al., 2008; Neckameyer and Weinstein, 2005).  Consistent with 
these studies, we find lower concentrations of dopamine in Sod-null flies, although two of the 
precursors to dopamine synthesis, phenylalanine and tyrosine, were not affected by the stress.  In 
contrast, PQ treated flies show no reduction in dopamine concentration, but were found to have 
lower concentrations of phenylalanine, and higher concentrations of tyrosine.  Our results across 
these two pathways reinforce the utility of the Sod-null genotype as a model of OS associated 
neurodegeneration in future studies. 
3.4.6 Amino acid metabolism affected by OS 
In addition to glutamine several other amino acids, and their associated metabolic pathways, 
were affected by the Sod-null mutation (Fig. 12).  Amino acids are not only building blocks for 
proteins but also have many intracellular roles, particularly under OS.  Proline, for example, has 
diverse anti-oxidant properties, modulates the redox environment, and contributes to the 
regulation of apoptosis in mammalian cells (Krishnan et al., 2008).  Proline concentrations were 
lower in flies exposed to both sources of OS, possibly because it is being expended for protective 
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purposes, or being funneled into glutamate synthesis.  In contrast to previous studies that 
document lower levels of arginine in disease related OS (Kochar and Umathe, 2009; Rodrigues 
Pereira et al., 2010), we find increased concentrations of arginine in Sod-nulls and unchanged 
levels in PQ treated flies.  The amino acid histidine has been demonstrated to reduce OS and 
tumor necrosis factor alpha-induced interleukin-8 secretion, which itself is linked to the pro-
oxidant inflammatory response, in intestinal cells (Son et al., 2005).  Lower concentrations of 
histidine may reflect it being expended to reduce OS and inflammation in the Sod-null and PQ 
treated flies.  Under OS, Pseudomonas fluorescens can repurpose histidine for the formation of 
the anti-oxidant, 2-oxoglutarate (Lemire et al., 2010), a response that flies under OS may share.  
Histidine concentrations are lower in Sod-nulls and PQ treated flies, possibly, because of demand 
for the metabolite in OS defense.  Histidine can be converted into the neurotransmitter histamine, 
which was also in lower concentration in Sod-nulls.  Histamine concentrations may be lower in 
Sod-nulls because of demand in OS defense, a role previously reported for the metabolite in cells 
supplemented with histamine (Hellstrand et al., 2000; Mahmood et al., 2012).  Alternatively, this 
may be part of a biochemical adaptation promoting dampened neuronal function, reducing the 
energetic demand for ATP synthesis via the electron transport chain.  Concordantly, the amino 
acid derivative N-acetylaspartate (NAA), which other studies have found to be located primarily 
in neural tissues (Clark, 1998), was in lower concentrations in Sod-nulls.  Increased NAA 
concentrations in mammalian brains results in higher levels of OS (Francis et al., 2012; 
Pederzolli et al., 2007b).  Decreased concentrations in Sod-nulls and unchanging concentrations 
in PQ treated flies may reflect a response to limit other sources of OS.  
3.4.7 Conclusions and future directions 
The Sod-null and PQ models of OS were used in this study as complementary systems to allow 
us to draw broader conclusions about the metabolomic response to OS.  The systems are similar 
in that they both generate excess concentrations of intracellular superoxide.  The systems are 
different in that in the PQ system the flies have functional SOD and can dismutate the radical to 
hydrogen peroxide.  The concentrations of superoxide or hydrogen peroxide in both systems are 
not yet known, though the differences in their concentrations may drive the metabolic differences 
seen between each stress. 
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In the PQ investigation, we initially screened two other wild-type lines along with the T5 
controls line from the Sod study.  The two wild-type lines were viable in concentrations at least 
an order of magnitude higher than T5 flies (data not shown).  To keep the concentrations 
consistent between T5 fly lines and wild-type lines, a 0.5 mM concentration was used.  This 
concentration did not elicit broad metabolic differences in the wild-type flies: a PCA could not 
differentiate between PQ treated wild-types and wild-types under benign conditions (data not 
shown).  Future studies will involve metabolomic analysis of more wild-type lines (genetic 
backgrounds) under further PQ induced stress.  Although T5 control lines were more sensitive to 
PQ exposure than wild-type lines, the metabolic profiles of T5 flies were similar to wild-type 
lines under benign conditions (Appendix C).  This similarity in metabolic profiles suggests that 
T5 control flies are good controls for metabolic analysis against the Sod-null model.  
Future investigations would benefit from an assessment of the contribution of genetic 
background to the metabolomic response of OS in D. melanogaster.  Genetic background effects 
can have substantial impact on the manifestation of genetic lesions or stress responses (reviewed 
in: Chandler et al., 2012; Gibson and Reed, 2008).  The results from this study provide insights 
into the metabolic response of D. melanogaster, however broad based conclusions could only be 
made once testing across multiple backgrounds can be completed. 
In this investigation we describe substantial changes to the metabolic profiles of D. melanogaster 
under genetic and chemical induced OS.  Almost a third of the measured metabolome of the Sod-
null model was altered in response to OS, and 13% of the measured metabolome was altered in 
flies chronically exposed to PQ.  The two sources of oxidative stress resulted in changes to 
glutamine metabolism, pantothenate and CoA synthesis, and central metabolism, highlighting the 
role these pathways have in OS.  The sources of OS were complementary to each other, however 
large differences in the metabolic profiles of flies under each stress highlight the general 
differences in the mechanisms of each stress.  Future studies will involve assessments of the role 
of genetic background on the metabolic profiles of flies under each stress.  
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Chapter 4 
4 General conclusions and future work 
We have developed a novel ion-pairing chromatography - mass spectrometry protocol for the 
resolution, detection, and quantification of biologically relevant, polar, molecules.  The newly 
developed protocol was validated through a reasonably extensive set of assessments including, 
ion-suppression, matrix effects, linearity, and limits of detection and quantification.  Using this 
protocol the metabolic profiles of a Sod-null genotype, paraquat induced stress, and four 
Drosophila species were determined.  We found that all components of all three biological 
systems could be differentiated base on metabolic profiles.  Future work will cover two large 
aspects of this research:  the technological and the biological.  Currently, our metabolite 
coverage identifies pieces of networks and processes that are affected by certain conditions.  
Future technological endeavors will aim to increase the comprehensiveness of our detected 
metabolites, which will fill in dimensions of networks that are currently incomplete, and provide 
us with a better understanding of biological implications.  The Sod-null experiments were 
performed on one genetic background, and the paraquat experiments on one genotype of the 
species.  Consequently, the metabolic responses observed in Chapters 2 and 3 may not reflect the 
entire suite of possible OS-induced changes across the species, or may only reflect line specific 
alterations.  Future work will investigate the effect of genetic background on metabolic profiles 
of Sod-null or paraquat induced stress.  This chapter will focus on avenues for future work that 
the current project could not focus on. 
4.1 Expanding metabolite coverage 
4.1.1 Chromatography:  Implications for increased metabolite detection 
Mass spectrometry using an ESI source is susceptible to ion suppression by compounds in the 
solvent and in complex biological matrices (Müller et al., 2002), an issue reviewed in section 1.3.  
In sections 2.3.2 and 2.3.3 both ion-suppression and matrix effects were determined to influence 
the signal of molecules in our samples using our protocol.  Although these levels of ion-
suppression are within acceptable limits (Böttcher et al., 2007; Knee et al., 2013), no amount of 
ion-suppression is ideal.  In targeted analyses with extensive sample preparations, ion-
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suppression can virtually be eliminated, however when the goal is comprehensive metabolite 
coverage, ion-suppression may be inevitable and can only be limited.  
The amount of ion suppression may be reduced with an effective chromatographic separation 
step preceding the mass spectrometer, for example IP-LC.  The IPR used in our protocol is 
effective at forming ion-pairs with negatively charged compounds, however compounds with 
more positive charges are not resolved.  Further, a large proportion of detected compounds in my 
analyses are found within the first minute of analysis (Fig. 1; Chapter 2).  These compounds 
containing more basic moieties are subject to the highest levels of ion-suppression (section 
2.3.3), complicating quantification of molecules in two ways.  Firstly, low abundance 
metabolites will not be detected in some, possibly any, analyses, because ion suppression will 
result in higher detection limits.  Secondly, the amount of ion suppression on a particular 
metabolite can vary between samples resulting in irreproducible peak areas, and by association, 
artifacts in statistical tests (Mallet et al., 2004b).  
Future endeavors in the Merritt lab will aim to resolve the molecules eluting early in the 
chromatographic run, effectively reducing, or eliminating, the effects of ion-suppression for 
these types of molecules.  Complementing our positively charged ion-pairing reagent, a 
negatively charged ion-pairing reagent is a possible direction for future separations.  For 
example, the negative charge from heptafluorobutyric acid (HFBA) has previously been used for 
analysis of positively charged ionic species, including many poorly retained in our protocol, in 
LC-MS based metabolomics (Vo Duy et al., 2012; Liu et al., 2013).  Negative and positive 
ionization modes correspond to analytical modes in which different charged species are drawn 
into a mass spectrometer.  During the ESI process, metabolites can be given a positive or 
negative charge.  Each metabolite has different susceptibilities to become negatively, or 
positively, charged depending on their chemical moieties, solvent pH and ionic strength, and co-
eluting molecules.  By switching the polarity of the mass spectrometers ion optics, either 
negative or positively charged species alone are introduced into the mass spectrometer and 
analyzed.  Ion-pairing reagents are undetectable in their respective analysis mode, negative or 
positive, because of their inability to be ionized in that polarity, but can be detected in the other 
mode.  For example, when a positively charged ion-pairing reagent is used in negative mode it is 
not detected, but when it is used in positive mode a signal will be seen and could contribute 
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greatly to ion-suppression and contamination within the mass spectrometer.  A negatively 
charged ion-pairing reagent would complement our analysis, however it would lead to system 
contamination in both analytical modes, which would be detrimental to analysis in either mode. 
A possible alternative to ion-pairing agents for the analysis of polar molecules is the use of 
HILIC as a separation technology.  The multi-modal separation properties of the silanols that 
make up the stationary phase in HILIC provide a level of versatility that can be used to retain 
different compounds by using various solvent conditions.  The acidity, composition, and 
presence of modifiers in the solvent can be altered to allow for different interactions amongst 
neutral, negatively, and positively charged compounds with the stationary phase.  This versatility 
suggests that many of the compounds eluting near the void volume can be analyzed with HILIC 
either in a complementary protocol or simultaneously with compounds already resolved within 
our protocol. 
The versatility of HILIC can be increased through the addition of various moieties to the 
stationary phase.  For example, having an alkylamide or an sulfoalkylbetaine moiety can add to 
the different levels of interactions with solvent, additives, and compounds (Buszewski and Noga, 
2012).  These types of zwitterionic moieties may facilitate the analysis of a wide range of 
compounds ranging in polarity and pKa because of the interactions between the positive and 
negatively charged species of the column.  In the Merritt lab, our goal is to perform 
comprehensive analysis, and these column types could provide the versatility we are trying to 
achieve (Bajad et al., 2006; Bratty et al., 2011; Kamleh et al., 2008).   
Broad metabolite coverage could also be achieved using multi-dimensional chromatographic 
systems (Dixon et al., 2006).  Multi-dimensional LC systems apply two or more, independent, 
orthogonal separations to a sample.  The aim of multi-dimensional chromatography is to use one, 
or multiple, separation techniques orthogonally on a sample that will resolve compounds that 
could not be resolved by the first dimension of separation.  This type of technique is particularly 
useful in separating complex matrices of compounds with varying chemical properties and has 
previously been demonstrated to be capable of resolving more features than 1D separation alone 
(Dixon et al., 2006; Li et al., 2013).  Multi-dimensional LC systems require a quaternary pump, 
capable of pumping four solvents simultaneously, or 2 separate LC systems.  Fortunately, for 
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those without these capabilities, a semi-orthogonal alternative is to use two columns, one 
immediately preceding the other, which will resolve compounds of varying types (Chalcraft and 
McCarry, 2013; Davis et al., 2001).   
4.1.2 Sample preparation 
In the previous section, I described how efficient chromatography could reduce the amount of 
ion-suppression during analysis, however there are several endogenous substances that can be 
removed prior to separation to also reduce ion suppression.  Metabolite extractions have different 
amounts of ion suppressing compounds depending on the solvent conditions and can also vary 
between extractions (Annesley, 2003).  In general, these substances are poorly retained on 
columns, or the manner in which they interact with the column generates long, asymmetrical, 
elution profiles (Müller et al., 2002).  Untargeted approaches such as ours aim to analyze the 
widest set of metabolites possible and in effort to avoid losing metabolites through various 
sample clean-up procedures, minimal sample preparation is performed.  This limited-processing 
approach leaves a maximum of possible metabolites in the homogenate, but the simple protein 
precipitation procedure also leaves other substances such as salts and phospholipids in the 
homogenate, which may contribute to ion suppression (Annesley, 2003).  It is possible that in our 
effort to avoid the loss of metabolites, ion suppression effects may have muted the signals of 
some metabolites, counteracting our goal of comprehensive metabolite analysis. 
There are several commercially available sample preparation options that may be explored in the 
future.  These options generally include a solid phase extraction (SPE) mechanism.  SPE is 
essentially a preparative chromatography step that combines size exclusion and chromatographic 
principles to remove protein and debris and also various types of other compounds.  Commercial 
SPE cartridges have been available since the late 1970’s with a wide variety of sorbent materials 
(Hennion, 1999).  SPE can be automized and even be included “on-line” (Negreira et al., 2013), 
meaning cleaning of the sample can be performed within a chromatographic run.  Specialized 
equipment is required for automation and on-line capabilities, but a moderately high-throughput 
option is to use a 96-well plate format.  The 96-well plate format options also require lower 
volumes of solvents, an important consideration when working with the small sample masses 
characteristic of Drosophila melanogaster, although the required volumes are larger than the 
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ones used in this thesis.  A hindrance encountered with initial sample preparation protocols was 
the inability to evaporate/concentrate our samples, which made SPE impractical.  A newly 
acquired vacuum concentrator in the Merritt lab has now removed this hindrance and work is 
currently underway to use higher extraction volumes and SPE, which can then be concentrated 
for LC-MS analysis. 
Amongst the wide variety of SPE sorbent types, ion exchange SPE and phospholipid specific 
SPE are the most probable candidates for future use in the Merritt lab.  Ion exchange based SPE 
has been successfully applied to remove protein and phospholipids from samples (Negreira et al., 
2013).  Ion exchange could also be used to remove the early eluting compounds from our ion-
pairing protocol, which would leave the negatively charged polar compounds in the analysis.  
The positively charged compounds isolated from ion exchange could also be fractioned for 
analysis using a complementary method to the method developed in this thesis.  This type of SPE 
would remove one type of charged species while allowing for the analysis of another and could 
be useful in the ion-pairing protocol.  Removal of compounds would, however, conflict with our 
final goal of comprehensive metabolomics, particularly if a chromatography protocol is 
developed which separates compounds of acidic, basic, and neutral properties. 
Alternatives to a classical mode of SPE include any of the several phospholipid specific removal 
SPE techniques.  Three examples of formats specifically designed for the removal of 
phospholipids are Waters Ostro™ (Waters Corporation), HybridSPE™ (Supelco Analytical, 
Sigma Aldrich), Phree™ (Phenomenex).  Each manufacturer claims these formats remove 
virtually all phospholipids while yielding high recovery of metabolites.  A metabolite recovery, 
matrix effect, and cost analysis would need to be performed on these technologies if utilized.  
These types of SPE are designed to be specific to phospholipids, but it is likely that some other 
compounds may have an affinity to the sorbent, and be lost for analysis. 
Sample clean-up techniques such as SPE remove large macromolecules, which can shorten 
column lifetimes.  An alternative method to remove large macromolecules from biological 
samples is the use of centrifugal filters (Wang et al., 2003), which work on a simple size 
exclusion principle.  This technique would remove large particulate matter that can lead to 
column blockage, however endogenous substances such as salts and phospholipids would 
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remain.  Centrifugal filters are meant as a size exclusive mechanism, however any surface would 
have some affinity to some compounds and it has been demonstrated that centrifugal filters do 
lead to poor recovery of certain types of compounds (Elhamili et al., 2011). 
In conclusion, sample preparation is a critical step in LC-MS analysis that is sometimes 
overlooked and can have large impacts on an analytical run.  Our sample analyses would benefit 
from lower levels of ion suppression and our UHPLC columns would have longer lifetimes.  
Implementing one of the potential cleaning methods would require each one to be assessed, 
which would have a time and financial commitment, but may provide long-term benefits. 
4.1.3 Broadening the scope of mass analyzer 
We have developed a simple protocol for the metabolic profiling of D. melanogaster and have 
successfully applied it to three biological systems.  In these three systems, the ion guides are 
optimized for compounds between 100-850 Da.  This mass range could potentially cover 
thousands of metabolites, however there are several metabolites that are of particular interest in 
the Merritt lab, for example pyruvate and glycine, which are below this mass range.  Previous 
work in the Merritt lab has focused on NADP reducing enzymes including Malic enzyme, which 
catalyzes the conversion of malate to pyruvate (Lum and Merritt, 2011; Rzezniczak and Merritt, 
2012; Rzezniczak et al., 2012).  Pyruvate is an important metabolite to analyze, particularly in a 
Malic enzyme knock-out, but we have not yet been able to quantify it.  Current work is under 
way to expand the mass range to approximately 50-1000 Da, which will generally cover the 
metabolites we are interested in quantifying.  The mass range used in this thesis was selected in 
an effort to achieve the highest sensitivity and broadening the range of masses we can analyze 
may also results in a decrease in sensitivity.  Initial screening does suggest, however, that the 
proposed expansion of mass range will have limited effects on sensitivity.  Analyzing a broader 
mass range will give us more complete picture of metabolism and aid in further understanding 
the processes affected by our systems. 
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4.2 Expanding biological significance 
4.2.1 Genetic background and oxidative stress 
The work described in this thesis provides a more complete understanding of the pleiotropic 
effects of a Sod-null allele generated decades ago.  Metabolic rearrangements could have 
different phenotypic manifestations depending on the genetic background, therefore the general 
applicability of this study to oxidative stress, SOD deficient animals, or even D. melanogaster, is 
currently unknown.  It has been demonstrated that Sod-null flies are subject to oxidative DNA 
damage (Woodruff et al., 2004), which may alter the overall genotype of the flies.  Coupled with 
years of rearing in laboratory conditions and a hypothetical acclimatization to oxidative stress, 
the flies we studied are most likely a unique genetic system with a unique metabolic profile.  We 
see striking differences between the altered metabolomes of the homologous Sod-null condition 
and those resulting from paraquat exposure in T5 control flies.  These differences may reveal 
underlying cellular responses to the type and amount of oxidative stress these sources cause, and 
highlight the importance of investigating multiple sources of oxidative stress.  A more complete 
picture of the general effects of loss of SOD activity will require varying levels and sources of 
oxidative stress, along with screening of multiple genetic backgrounds. 
Drosophila melanogaster is a metropolitan species of fruit fly with a wide range of habitat, from 
tropical African rainforests to the boreal forest of Northern Ontario.  Previous studies that have 
isolated D. melanogaster lines from different geographic locations documented large amounts of 
genetic variation between populations (Lachance and True, 2010; Oakeshott et al., 1984).  
Individual chromosomes that have originated from a certain location and that have a unique 
genomic structure are considered a genetic background.  Wild type individuals have a range of 
genetic differences that confer a genetic potential that may only manifest when subject to a 
genetic lesion or stressor, potentially affecting the phenotypic response of the lesion or stress 
(Gibson and Reed, 2008).  It is thus important to consider genetic background in any study 
involving a stress or genetic perturbation that results in a specific phenotype. 
The concept of genetic background is an often overlooked aspect in various studies, however it 
can have large implications on the validity of a biological observation.  For example, it has been 
demonstrated that the scallopedE3 wing mutant phenotype results in a variety of changes to wing 
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shape depending on the genetic background it is in (Dworkin et al., 2009).  In this wing system, 
without prior knowledge of the genetic lesion, one could come to the conclusion that the 
different visible wing mutations are different genetic mutations, instead of the same mutations in 
different backgrounds.  Genetic background effects also contribute to changes in functional 
genomic studies.  Levels of transcripts and proteins can vary between the same species 
depending on genetic background (Sarup et al., 2011; Zhong et al., 2012).  In most cases, there 
will be a lower number of significantly different features that are shared across all genetic 
backgrounds compared to the number of changes that appear to be background specific (Sarup et 
al., 2011). 
Broad metabolic differences driven by different genetic backgrounds and external factors have 
hindered the widespread usage of LC-MS based screening for biomedical purposes (Johnson and 
Gonzalez, 2012).  Human studies account for some variation in genetic background and 
environment depending on the level of random sampling, however this is often not enough to 
make broad based conclusions about the species as a whole.  To give an example, a thorough 
investigation of 262 clinical samples was performed to discover biomarkers for the progression 
of benign, localized, and metastatic cancer progression (Sreekumar et al., 2009).  Over 1000 
common features were detected in this analysis, but even through the quite different 
pathophysiological conditions, only six metabolites were detected at significantly different levels 
between each stage of disease.  In this investigation, the metabolite sarcosine was the most 
promising candidate for biomarker diagnosis and further genetic and cell invasion implications 
were investigated (Sreekumar et al., 2009).  Two independent follow-up studies from Germany 
and The People’s Republic of China attempted to replicate the results from Sreekumar et al. 
(2009).  Using complimentary MS based techniques, the follow-up studies did not find a 
significant role for sarcosine as a biomarker for prostate cancer progression (Jentzmik et al., 
2010; Wu et al., 2011).  Whether the differences in metabolome between each study were driven 
by genetic background, environment, or a combination of both, is unknown, however these types 
of differences in the results of functional genomic studies highlight the need to look across 
different genetic backgrounds. 
In model species such as D. melanogaster where there is the possibility of making lines virtually 
isogenic, it is especially important to consider the effects of genetic variation when studying key 
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metabolic processes.  One of the major advantages of working with Drosophila is the ease of 
rearing and acquiring sample numbers, which makes accounting for genetic variation relatively 
simple.  Genetic background effects often present themselves when an organism is subject to a 
stress or test condition, and these types of effects are referred to as cryptic genetic variation 
(reviewed in: Gibson and Reed, 2008).  Cryptic genetic variation has been observed to affect the 
metabolic profiles of long lived D. melanogaster (Sarup et al., 2012), which has implications in 
the metabolic studies in the Merritt lab. 
The metabolic response to oxidative stress in D. melanogaster may also be affected by genetic 
background variation.  The Merritt lab is currently exploring possibilities to assess the variation 
in metabolomic signals in D. melanogaster as a result of oxidative stress.  The Sod-null and the 
T5 transgenic control model are proving a difficult model to test for background effects.  The 
native wild type copy of cytosolic Superoxide dismutase is located on the third chromosome, 
while the transgene inserted into the T5 line is located on the second chromosome (Parkes et al., 
1993).  Generally background, or chromosome, replacements, whereby entire chromosomes can 
be replaced with another, can be performed to add genetic variation to a model (Lum and Merritt, 
2011; Rzezniczak and Merritt, 2012).  However, since the Sod null allele and the Sod rescue 
transgene are on different chromosomes, changing any chromosome will make the models 
different and the transgene could no longer serve as a control.  For this type of added variation to 
function double chromosomal replacements must be performed, or a method for transferring the 
transgene to the third chromosome may be performed. 
A simpler way to add genetic variation to our study is by generating, via an alternative 
mutagenesis, a different SOD deficient fly and subsequent chromosomal replacement.  Work is 
currently underway to generate knock-out alleles through P-element mutagenesis.  P-element 
mutagenesis uses excision of mobile genetic elements inserted near a gene of interest to create 
local chromosomal lesions (Hummel and Klämbt, 2008).  Fly lines with a P-element inserted 
near a gene of interest, but missing the transposase gene, the gene product that is required for P-
element mobilization, are obtained from stock centers.  P-element lines can be crossed with a 
line that contains a transposase source, which will mobilize the P-element.  P-elements excise 
from the genome and at a low, but appreciable frequency, and take with them random segments 
of DNA flanking the element.  Most alleles are repaired using the sister chromosome as a 
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template, generating 100%, “normal” or wild-type, activity alleles.  When repair is not perfect 
the gene products can have altered activities, including reduced, increased or knocked-out 
activity alleles.  Once created, P-element excision derived alleles can be established as individual 
lines.  A suite of different alleles, differing in the genomic lesion, and in gene activity, can be 
collected and established as independent lines.  This set would consist of control alleles 
(“normal” activity) and knock-down alleles, all of which are isogenic except for the small 
mutation at the excision site.  These isogenic sets are then good models for experimental 
comparisons with virtually no genetic variation.  To introduce controlled genetic variation, a 
homozygous P-element mutated fly can be mated with a fly of a different genetic background to 
create heterozygous flies that can be experimentally tested (Rzezniczak and Merritt, 2012).  
Unfortunately, not all P-element insertions are in a region of a gene whose deletion will generate 
alleles of interest and some complete knock-outs are non-viable, i.e. not all P-element excisions 
result in change of activity mutations (Hummel and Klämbt, 2008).  Currently, the Merritt lab is 
attempting to generate such a matched set for Sod, but only one P-element is line is publicly 
available and, so far, this line has failed to produce knock-out excisions.  
Finally, RNA interference (RNAi) may be a viable option for generating activity variant flies.  
RNAi induced suppression can be used to create, a suite of activity variant flies and has 
successfully been applied to generate SOD2 (the mitochondrial Sod locus) silenced flies (Kirby 
et al., 2002).  A possible downside to this particular technique is that almost all genes have 
internal sequences with sequence similarity to other genes, meaning that RNAi may down-
regulate many off-target sites (Seinen et al., 2010).  Despite the possibility of off-target 
deregulation RNAi is a commonly used technique for altering gene activity and Sod1 RNAi lines 
are available at the Vienna Drosophila RNAi Center (Transformant IDs: 31551 and 108307). 
4.2.2 Paraquat induced stress and genetic background 
In my thesis research, transgenic rescue control lines (T5) were treated with paraquat and then 
subject to LC-MS analysis.  This is the first study that takes a broad based metabolomics 
approach to observe changes in metabolite levels after paraquat administration.  Our results 
indicate that paraquat has a broad biological and metabolomic effect.  We observed many 
changes to the metabolic profile of paraquat-induced stress. These observations bring us closer to 
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understanding the metabolic impact of oxidative stress.  In this investigation, as in the Sod-null 
comparison, the importance of genetic background was not thoroughly assessed.  Two separate 
fly lines, VT83 and 6326, were used to allow us to draw some general (i.e. not simply line-
specific) conclusions about the metabolic impact of paraquat induced stress.  T5 flies were 
included in this screen because they act as the wild-type controls for Sod-null flies.  Because 
paraquat concentration had to be kept low to allow inclusion of the T5 control (which only has 
60% SOD activity), neither wild-type line showed strong paraquat responses.  This study did add 
another level of understanding past the use of a Sod-null allele alone, however more can be done 
in the future. 
Testing genetic background effects on the metabolomic response to paraquat treatment is simpler 
than testing those effects in the Sod-null system.  6326 and VT83 lines were viable in 
concentrations of at least 5 mM paraquat, while T5 lines were only viable in a maximum of 0.5 
mM paraquat.  The low level of paraquat used was not sufficient to observe substantial changes 
to the metabolic profiles of the wild type lines.  A first step in future studies with paraquat would 
simply be an assessment of the maximum paraquat concentration in which 6326, VT83, and a 
sample of isofemale lines from the wild, survive.  Based on the response of the T5 lines to 
paraquat at their maximum tolerance level, this assessment at near-lethal concentrations of 
paraquat should elicit broad physiological and metabolomic changes in wild-type flies.  Using 
multiple lines would also provide us a better understanding of what metabolic differences are 
altered in a genetic background specific manner, and which metabolite responses are shared 
across the backgrounds.  Considering the genetic variation across multiple lines, there would 
most likely be a wide range of maximum concentrations in which the lines are viable.  A 
concentration of paraquat in which a 50% decrease in viable adults is observed can be used to 
maintain a similar impact to all fly lines. 
4.2.3 Species-specific metabolic profiles 
As part of this thesis, I performed an exploratory investigation of species-specific metabolic 
profiles (Knee et al., 2013).  There were substantial differences in the levels of metabolites in 
each species allowing the metabolic profiles to be resolved using PCA or heat maps.  There is 
also evidence that within species metabolic profiles differ enough to resolve different isofemale 
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lines (Fig. 7).  This experiment was designed as a proof-of-principle pilot study and though it did 
indicate a number of interesting features, future work is required for a better understanding of 
species-specific metabolomics. 
The largest limitation to this study was the small sample sizes used in the analysis: four samples 
of each isofemale line.  I included three wild-caught isofemale lines for each species sampled, 
with the exception of D. hydei for which only one line was available.  This investigation served 
as a good exploratory study, however sample replication and types must be much larger to draw 
conclusions about species-specific metabolite profiles.  Despite the remarkable similarities in the 
global metabolic profiles of D. hydei and D. immigrans they were distinguishable by PCA 
(Appendix B), but because there were only four biological replicates from one isofemale line, 
broad based conclusions about the metabolic profile of D. hydei cannot be made.  We cannot 
conclude whether all D. hydei have similar metabolic profiles to D. immigrans, or whether the D. 
hydei line we isolated was uniquely similar in metabolic profile to D. immigrans in which case if 
we sample more lines we may observe wider separation.  In Appendix B there is evidence that 
the metabolic profiles of D. melanogaster can be resolved using PCA.  In contrast, Appendix C 
illustrates an example where T5 control lines cannot be metabolically distinguished from 6326 
lines. In collaboration with a group from the University of Guelph a metabolomic comparison 
was made between D. suzkii originating from British Columbia and Ontario, and the metabolite 
profiles between the fly lines could not be resolved using PCA (Data not shown).  These 
examples highlight the need for larger numbers of lines to assay using LC-MS analysis, before 
making broad based conclusions about species-specific or line-specific metabolomes. 
All four species in the LC-MS comparison are cosmopolitan species of Drosophila, however 
they were all reared on a medium optimized for D. melanogaster and had been reared in 
laboratory for several generations at the time of assay.  The type and content of the food type 
Drosophila are reared under affects metabolism and related processes (Matzkin et al., 2011, 
2013; Reed et al., 2010).  Work is currently under way in the Merritt lab to assess the metabolic 
effects of rearing Drosophila under different food media using LC-MS analysis.  Observing 
changes to the metabolic profiles from rearing flies under different conditions will provide better 
understanding of the processes involved in laboratory rearing of Drosophila and give us a better 
picture of the metabolic signature of different species under lab conditions.  Drosophila under 
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lab conditions are remarkably different from Drosophila found in the wild, and it is has been 
shown that in very few generations, genomic sequences will already be altered in response to 
selection for laboratory conditions (Orozco-terWengel et al., 2012).  The number of generations 
in which the flies used in this study were kept in the lab was minimized, however the extent to 
which lab adaptation had taken place is unknown.  This unknown limits our ability to generalize 
our conclusions about the species-specific metabolome in the wild.  Future studies involving 
Drosophila isolated from the wild will benefit from both assaying flies reared under different 
media and minimizing laboratory rearing times, with the possibility of assaying at various 
generations once established in the lab. 
4.3 LC-MS technology beyond oxidative stress and Drosophila 
The Sod-null induced stress and the paraquat induced stress models investigated in this thesis 
were chosen, in part, because of the large physiological changes that oxidative stress confer 
which we expected would result in changes to the metabolome.  Being the first metabolomic 
investigation in the Merritt lab, method development consumed a substantial amount of time and 
effort, and conditions that were most likely to affect the metabolome were most appealing 
avenues for investigation.  This approach was rewarded when almost one third of the detected 
metabolome of Sod-nulls were altered compared to controls; being able to detect these large-
scale differences in a biological system validated our method.  By analyzing three different 
systems, a Sod-null allele, paraquat induced stress, and the metabolome of different species, we 
demonstrated that the method we designed was versatile and robust.  With alterations to sample 
preparation, the protocol used in this thesis can be employed on any model organism or for food 
and drug investigations, an advantage it shares with other LC-MS designs (Cubbon et al., 2010; 
Lee et al., 2010; Sreekumar et al., 2009). 
Previous work in the Merritt lab has involved describing changes in the relatively small 
metabolic network of NADP reducing enzymes, particularly under different genetic backgrounds 
and stresses (Lum and Merritt, 2011; Rzezniczak and Merritt, 2012).  Different excision alleles 
have been assessed for soluble triglyceride levels, total carbohydrate content, and soluble protein 
content (Rzezniczak and Merritt, 2012).  These final phenotypes are useful yet non-specific, 
considering there are more than one type of each of these particular biological compounds.  
Soluble proteins for example, consist of a large suite of proteins with broad biochemical 
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functions, and the unique concentration of each protein has many biological implications that 
cannot be elucidated by quantifying the concentration of all proteins of this type.  Broad based 
LC-MS metabolomics is expected to shed light on many processes currently not assessed in these 
previous investigations.  Not only could this approach quantify the relative steady state 
concentrations of the substrates, products, and cofactors involved in the enzyme networks under 
investigation, it could identify changes to networks and processes that would otherwise be 
missed, or justify speculations made in these studies.  
The Merritt lab is also interested in microbial communities of acid mine drainage (AMD) ponds 
(Auld et al., 2013).  There are projects currently underway aimed at culturing a suite of microbes 
that live in AMD with the intention of using them for LC-MS metabolomics.  Little is known 
about the unique microbial community found in the Sudbury AMD site other than what microbes 
are present (Auld et al., 2013).  The protocol presented in this thesis can be used to elucidate 
unique metabolic profiles of different microbes in AMD to gain a better understanding of what 
metabolic requirements are needed to survive in AMD and what certain microbes are 
contributing to the community.  
4.4 Conclusion 
The results from my research describe the metabolic profiles of D. melanogaster under chronic 
oxidative stress and the metabolic profiles of four Drosophila species. The metabolic profiles of 
the Drosophila were elucidated by a newly developed, and herein validated, LC-MS protocol for 
the quantification of polar metabolites.  The Sod-null allele and paraquat administration are both 
sources of oxidative stress, which result in substantial, but unique changes to the metabolic 
profile of D. melanogaster.  Developing new sample preparation and chromatographic protocols 
will allow for quantification of a broader suite of metabolites, which will increase our 
understanding of the metabolic processes affected by genetic lesion or stress.  To obtain general 
conclusions about oxidative stress in Drosophila melanogaster LC-MS analysis of oxidative 
stress in different genetic backgrounds need to be performed.  
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Appendices 
Appendix A: PCA loadings and score plots representing the metabolic profiles of A) 
paraquat treated T5 lines vs. T5 control lines, and B) four Drosophila species. 
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Appendix B: PCA loadings and score plots representing the metabolic profiles of four 
Drosophila species. 
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Appendix C: Comparison of transgenic rescue lines with wild-type lines 
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Appendix D: Relative standard deviations (RSD) of the area under the curve, for five 
replicates, of injections containing 16 compounds that elute near the void volume. 
Metabolite RSD (%) 0.8 ppm 5 ppm 50 ppm 
Arginine 3.58 6.38 2.02 
Asparagine 10.68 11.52 2.56 
Cysteine 36.54 2.14 2.50 
Dopamine  125.92 2.49 
Glutamine 3.47 5.02 2.04 
Histidine 4.77 3.98 1.70 
Leucine 14.67 4.03 2.80 
Lysine 12.86 5.45 2.07 
Methionine 45.24 4.03 4.24 
Ornithine 4.86 2.78 3.51 
Proline 5.22 4.33 2.26 
Serine 10.42 9.24 6.11 
Threonine 14.14 4.15 2.78 
Trehalose 3.58 3.67 3.65 
Tryosine 5.51 5.75 1.02 
Valine 19.44 9.97 3.34 
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Appendix E: Significantly altered metabolites in the Sod-null genotype (post-tandem MS) 
Metabolite P-value Ratio (Sod-nulls/controls) 
Fold (Sod-
nulls/controls) 
Pathway placement 
(From: Table 5) 
Pantothenate 0 0.47 -2.11 1 
Dopamine 0 0.7 -1.43 15 
Histamine 0 0.73 -1.37 17 
Glutamine 0 1.42 1.42 2,3,4,5,6,7,18,39 
Threonine 0 1.49 1.49 7,10,11,44 
UDP-n-acetyl 
glucosamine 0 0.78 -1.29 9 
Trehalose 0 0.77 -1.29 13 
Gluconate 0 2.01 2.01 8 
Methionine 0 1.77 1.77 7,12 
Sedoheptulose 
7-phosphate 0 1.79 1.79 8 
Cytidine 0 0.68 -1.48 4 
N-
acetlyaspartate 0 0.76 -1.31 6 
Phosphotyrosin
e 0 1.59 1.59 - 
glucose/fructose
/etc 0 0.82 -1.22 - 
AMP 0 0.93 -1.08 18 
Glycerophospha
tes 0 0.84 -1.2 - 
GSSG 0 1.48 1.48 26 
Histidine 0.00001 0.88 -1.13 7,17 
Arginine 0.00001 1.11 1.11 2,7 
UMP 0.00007 0.76 -1.32 4 
Asparagine 0.00026 1.44 1.44 6,7,43 
Pyroglutamate 0.00047 1.2 1.2 19 
Valine 0.00074 1.37 1.37 1,7,10,30,41,43 
Trehalose 6-
phosphate 0.00119 0.72 -1.38 13 
NAD 0.00168 0.84 -1.19 24 
FAD 0.00176 0.86 -1.16 33 
(Iso)leucine 0.0028 1.13 1.13 - 
Ornithine 0.00289 1.11 1.11 2,19 
n-acetyl-
glutamate 0.0029 1.4 1.4 2 
Hexose-
phosphates 0.00436 1.19 1.19 - 
Biopterin 0.00443 1.54 1.54 - 
Urate 0.00724 0.59 -1.7 18 
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Metabolite P-value Ratio (Sod-nulls/controls) 
Fold (Sod-
nulls/controls) 
Pathway placement 
(From: Table 5) 
CoA 0.00855 0.84 -1.2 1,25 
ATP 0.01047 0.74 -1.35 18 
Acetyl-CoA 0.0136 0.73 -1.37 
10,21,23,25,26,27,
28,29,30,31,32,34,
38,39,41,42, 
Proline 0.01899 0.9 -1.11 2,7 
ADP 0.06343 0.89 -1.12 18 
Cysteine 0.12442 0.87 -1.15 1,7,11,12,19 
Tyrosine 0.14594 1.07 1.07 7,15,20,21,45 
Phospho 
ethanolamine 0.15359 0.96 -1.04 14,37 
Phenylalanine 0.17352 0.94 -1.07 7,20,21,43 
Malate 0.23028 1.09 1.09 23,38,39,42 
Serine 0.23335 0.87 -1.15 7,11,12,38,39,42,43 
Oxoglutarate 0.24111 1.15 1.15 5,6,17,23,26,39 
Lysine 0.33527 1.1 1.1 7,27,40 
Inosine 0.61143 1.08 1.08 18 
Mannose 6-
Phosphate 0.63373 1.12 1.12 9,36 
NADH 0.67924 0.93 -1.07 - 
Aspartate 0.78293 0.96 -1.04 1,2,6,7,11,12,17,24,41,43 
Succinate 0.82429 1 1 6,15,21,23,26 
Glutamate 0.87853 1 1 2,3,5,6,7,17,19,26,39,44 
Fumarate 0.89018 1.02 1.02 23,6,2,15,21,26,24 
GSH 0.95284 1 -1 19 
(Iso)citrate 0.99008 1 -1 - 
NADP Absent in Sod-nulls 19 
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Appendix F: Significantly altered metabolites in paraquat treated flies (post-tandem MS) 
Metabolite P-value Ratio (PQ/controls) 
Fold 
(PQ/controls) 
Pathway placement 
(From: Table 5) 
Sedoheptulose 7-
phosphate 0 4.64 4.64 8 
Panothenate 0 0.55 -1.83 1 
Gluconate 0 0.12 -8.37 8 
Glutamine 0 1.9 1.9 2,3,4,5,6,7,18,39 
GSH 0 1.31 1.31 19 
Trehalose 0 1.2 1.2 13 
(Iso)leucine 0.00048 0.79 -1.27 - 
Lysine 0.00063 1.51 1.51 7,27,40 
Tyrosine 0.00074 1.27 1.27 7,15,20,21,45 
Histidine 0.00179 0.87 -1.15 7,17 
Hexose-phosphates 0.0022 1.33 1.33 - 
Trehalose 6-phosphate 0.00284 1.38 1.38 13 
Proline 0.00318 0.78 -1.28 2,7 
Asparagine 0.00483 1.54 1.54 6,7,43 
Phenylalanine 0.01427 0.8 -1.25 7,20,21,43 
UMP 0.01984 1.17 1.17 4 
GSSG 0.02696 1.24 1.24 26 
Arginine 0.06045 0.85 -1.17 2,7 
Phospho ethanolamine 0.06951 0.85 -1.17 14,37 
Threonine 0.09878 0.81 -1.24 7,10,11,44 
Phosphotyrosine 0.10366 0.84 -1.18 - 
(Iso)citrate 0.10632 1.2 1.2 - 
Aspartate 0.14159 1.1 1.1 1,2,6,7,11,12,17,24,41,43 
Biopterin 0.18875 1.19 1.19 - 
CoA 0.25249 0.81 -1.23 1,25 
Mannose 6-phosphate 0.27072 1.37 1.37 9,36 
Malate 0.33153 0.74 -1.36 23,38,39,42 
Dopamine 0.37476 1.06 1.06 15 
Succinate 0.39438 1.05 1.05 6,15,21,23,26 
N-acetylaspartate 0.40839 0.91 -1.09 6 
Inosine 0.43673 0.87 -1.15 18 
ATP 0.44062 0.84 -1.19 18 
Glutamate 0.56141 1.04 1.04 2,3,5,6,7,17,19,26,39,44 
Glyceraldehyde 3-
phosphate 0.5772 1.1 1.1 8,29,34,36,42 
AMP 0.66482 1.02 1.02 18 
Glycerophosphates 0.71192 0.96 -1.04 - 
UDP-n-acetyl glucosamine 0.74556 1.05 1.05 9 
Ornithine 0.77702 0.97 -1.03 2,19 
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Metabolite P-value Ratio (PQ/controls) 
Fold 
(PQ/controls) 
Pathway placement 
(From: Table 5) 
NADH 0.78073 1.06 1.06 - 
(Iso)citrate 0.82373 0.95 -1.06 - 
NAD 0.82795 0.98 -1.02 24 
ADP 0.88741 0.98 -1.02 18 
Histamine 0.8878 1.01 1.01 17 
Pyroglutamate 0.89187 0.99 -1.01 19 
FAD 0.96348 1.01 1.01 33 
 
